ID,Description,setSize,enrichmentScore,NES,pvalue,p.adjust,qvalues,ont,comparison
GO:0030055,cell-substrate junction,358,0.399986836766063,1.7972831195132,0.00346020761245675,0.0369152970922882,0.0277463570430501,CC,mono-sp-vs-hc
GO:0070161,anchoring junction,426,0.388679228882743,1.7674646203817,0.00347222222222222,0.0369152970922882,0.0277463570430501,CC,mono-sp-vs-hc
GO:0005578,proteinaceous extracellular matrix,179,0.344058621522587,1.4264456777581,0.00350877192982456,0.0369152970922882,0.0277463570430501,CC,mono-sp-vs-hc
GO:0005924,cell-substrate adherens junction,354,0.401332843188263,1.79799242145383,0.00350877192982456,0.0369152970922882,0.0277463570430501,CC,mono-sp-vs-hc
GO:0005912,adherens junction,413,0.394252536638781,1.78503639946784,0.00354609929078014,0.0369152970922882,0.0277463570430501,CC,mono-sp-vs-hc
GO:0005925,focal adhesion,351,0.401720138140345,1.79372714112986,0.00354609929078014,0.0369152970922882,0.0277463570430501,CC,mono-sp-vs-hc
GO:0031012,extracellular matrix,221,0.356131387258174,1.51938962850739,0.00354609929078014,0.0369152970922882,0.0277463570430501,CC,mono-sp-vs-hc
GO:0000785,chromatin,388,0.318170876241903,1.43943621215554,0.0036231884057971,0.0369152970922882,0.0277463570430501,CC,mono-sp-vs-hc
GO:0098797,plasma membrane protein complex,346,0.359861665718416,1.62764366059704,0.00373134328358209,0.0369152970922882,0.0277463570430501,CC,mono-sp-vs-hc
GO:0005911,cell-cell junction,288,0.345155877182373,1.50695819205615,0.00374531835205993,0.0369152970922882,0.0277463570430501,CC,mono-sp-vs-hc
GO:0098552,side of membrane,347,0.37136730250126,1.66919194359776,0.0037593984962406,0.0369152970922882,0.0277463570430501,CC,mono-sp-vs-hc
GO:0000786,nucleosome,73,0.57110242352882,2.1115662544969,0.00380228136882129,0.0369152970922882,0.0277463570430501,CC,mono-sp-vs-hc
GO:0072562,blood microparticle,75,0.445002490561713,1.64499642527116,0.00380228136882129,0.0369152970922882,0.0277463570430501,CC,mono-sp-vs-hc
GO:0005778,peroxisomal membrane,53,-0.592261155175628,-2.0549033099415,0.00381679389312977,0.0369152970922882,0.0277463570430501,CC,mono-sp-vs-hc
GO:0015030,Cajal body,46,-0.503393884025548,-1.65812540296446,0.00381679389312977,0.0369152970922882,0.0277463570430501,CC,mono-sp-vs-hc
GO:0015629,actin cytoskeleton,370,0.326284000787733,1.46120339915533,0.00381679389312977,0.0369152970922882,0.0277463570430501,CC,mono-sp-vs-hc
GO:0019897,extrinsic component of plasma membrane,108,0.483326929867467,1.89556461523012,0.00381679389312977,0.0369152970922882,0.0277463570430501,CC,mono-sp-vs-hc
GO:0019898,extrinsic component of membrane,209,0.340335883465239,1.45542017369194,0.00381679389312977,0.0369152970922882,0.0277463570430501,CC,mono-sp-vs-hc
GO:0031903,microbody membrane,53,-0.592261155175628,-2.0549033099415,0.00381679389312977,0.0369152970922882,0.0277463570430501,CC,mono-sp-vs-hc
GO:0043235,receptor complex,217,0.369869649088455,1.58182306572207,0.00381679389312977,0.0369152970922882,0.0277463570430501,CC,mono-sp-vs-hc
GO:0016528,sarcoplasm,50,0.471659113891594,1.61603425837108,0.00383141762452107,0.0369152970922882,0.0277463570430501,CC,mono-sp-vs-hc
GO:0000313,organellar ribosome,69,-0.54294614236393,-1.9306320819916,0.00384615384615385,0.0369152970922882,0.0277463570430501,CC,mono-sp-vs-hc
GO:0005761,mitochondrial ribosome,69,-0.54294614236393,-1.9306320819916,0.00384615384615385,0.0369152970922882,0.0277463570430501,CC,mono-sp-vs-hc
GO:0005775,vacuolar lumen,66,0.454221104261439,1.63993743661038,0.00384615384615385,0.0369152970922882,0.0277463570430501,CC,mono-sp-vs-hc
GO:0009898,cytoplasmic side of plasma membrane,132,0.475529633878874,1.96189620316947,0.00384615384615385,0.0369152970922882,0.0277463570430501,CC,mono-sp-vs-hc
GO:0030686,90S preribosome,23,-0.708780615114634,-2.05461068307845,0.00384615384615385,0.0369152970922882,0.0277463570430501,CC,mono-sp-vs-hc
GO:0044433,cytoplasmic vesicle part,446,0.299602665538961,1.36946669345728,0.00384615384615385,0.0369152970922882,0.0277463570430501,CC,mono-sp-vs-hc
GO:0000790,nuclear chromatin,258,0.366805309429817,1.58483264378706,0.00386100386100386,0.0369152970922882,0.0277463570430501,CC,mono-sp-vs-hc
GO:0005834,heterotrimeric G-protein complex,23,0.77560142500457,2.26633620706044,0.00387596899224806,0.0369152970922882,0.0277463570430501,CC,mono-sp-vs-hc
GO:0030027,lamellipodium,149,0.355068894948981,1.43606541994469,0.00387596899224806,0.0369152970922882,0.0277463570430501,CC,mono-sp-vs-hc
GO:0031253,cell projection membrane,215,0.358054300143435,1.51359410612514,0.00387596899224806,0.0369152970922882,0.0277463570430501,CC,mono-sp-vs-hc
GO:0005777,peroxisome,116,-0.398863029901965,-1.5680405580676,0.00389105058365759,0.0369152970922882,0.0277463570430501,CC,mono-sp-vs-hc
GO:0042579,microbody,116,-0.398863029901965,-1.5680405580676,0.00389105058365759,0.0369152970922882,0.0277463570430501,CC,mono-sp-vs-hc
GO:0043202,lysosomal lumen,65,0.458048077835203,1.64063666682035,0.00389105058365759,0.0369152970922882,0.0277463570430501,CC,mono-sp-vs-hc
GO:0034774,secretory granule lumen,44,0.58252501548576,1.96066905813343,0.00392156862745098,0.0369152970922882,0.0277463570430501,CC,mono-sp-vs-hc
GO:0044452,nucleolar part,58,-0.571225833601825,-2.01745921484147,0.00392156862745098,0.0369152970922882,0.0277463570430501,CC,mono-sp-vs-hc
GO:0032040,small-subunit processome,32,-0.741084292036007,-2.29408988293392,0.00393700787401575,0.0369152970922882,0.0277463570430501,CC,mono-sp-vs-hc
GO:0000314,organellar small ribosomal subunit,25,-0.660293057578177,-1.86986608024395,0.00395256916996047,0.0369152970922882,0.0277463570430501,CC,mono-sp-vs-hc
GO:0001726,ruffle,142,0.410383681350463,1.6628550038181,0.00395256916996047,0.0369152970922882,0.0277463570430501,CC,mono-sp-vs-hc
GO:0005763,mitochondrial small ribosomal subunit,25,-0.660293057578177,-1.86986608024395,0.00395256916996047,0.0369152970922882,0.0277463570430501,CC,mono-sp-vs-hc
GO:0044437,vacuolar part,344,0.295323890543311,1.32356887436249,0.00395256916996047,0.0369152970922882,0.0277463570430501,CC,mono-sp-vs-hc
GO:0098562,cytoplasmic side of membrane,144,0.448708141834598,1.8652216613262,0.00395256916996047,0.0369152970922882,0.0277463570430501,CC,mono-sp-vs-hc
GO:0030684,preribosome,49,-0.702604639399516,-2.42467146262108,0.00396825396825397,0.0369152970922882,0.0277463570430501,CC,mono-sp-vs-hc
GO:0031093,platelet alpha granule lumen,38,0.594670757396606,1.9250099473183,0.00396825396825397,0.0369152970922882,0.0277463570430501,CC,mono-sp-vs-hc
GO:0044438,microbody part,77,-0.493128117220611,-1.82509280190151,0.00396825396825397,0.0369152970922882,0.0277463570430501,CC,mono-sp-vs-hc
GO:0044439,peroxisomal part,77,-0.493128117220611,-1.82509280190151,0.00396825396825397,0.0369152970922882,0.0277463570430501,CC,mono-sp-vs-hc
GO:0044815,DNA packaging complex,79,0.527351295512405,1.9549822755324,0.00396825396825397,0.0369152970922882,0.0277463570430501,CC,mono-sp-vs-hc
GO:0030175,filopodium,74,0.436452930169833,1.61701104352629,0.00398406374501992,0.0369152970922882,0.0277463570430501,CC,mono-sp-vs-hc
GO:0044291,cell-cell contact zone,52,0.49366172948867,1.67572348223368,0.00398406374501992,0.0369152970922882,0.0277463570430501,CC,mono-sp-vs-hc
GO:0016471,vacuolar proton-transporting V-type ATPase complex,12,0.774461677466431,1.89544098576424,0.004,0.0369152970922882,0.0277463570430501,CC,mono-sp-vs-hc
GO:0098857,membrane microdomain,246,0.343360801974969,1.46544129280799,0.004,0.0369152970922882,0.0277463570430501,CC,mono-sp-vs-hc
GO:0008305,integrin complex,25,0.733959568942627,2.19038739099337,0.00401606425702811,0.0369152970922882,0.0277463570430501,CC,mono-sp-vs-hc
GO:0031252,cell leading edge,307,0.363098371802816,1.61156725944929,0.00401606425702811,0.0369152970922882,0.0277463570430501,CC,mono-sp-vs-hc
GO:0098636,protein complex involved in cell adhesion,25,0.733959568942627,2.19038739099337,0.00401606425702811,0.0369152970922882,0.0277463570430501,CC,mono-sp-vs-hc
GO:0031234,extrinsic component of cytoplasmic side of plasma membrane,78,0.549744153154894,2.06566373240211,0.00403225806451613,0.0369152970922882,0.0277463570430501,CC,mono-sp-vs-hc
GO:0031256,leading edge membrane,108,0.424010200824978,1.66585205716234,0.00403225806451613,0.0369152970922882,0.0277463570430501,CC,mono-sp-vs-hc
GO:0045121,membrane raft,245,0.34472207008362,1.46817788158301,0.00403225806451613,0.0369152970922882,0.0277463570430501,CC,mono-sp-vs-hc
GO:0016604,nuclear body,328,-0.305928808058231,-1.38642802498166,0.00404858299595142,0.0369152970922882,0.0277463570430501,CC,mono-sp-vs-hc
GO:0042734,presynaptic membrane,32,0.64699658603977,1.98412569989718,0.0040650406504065,0.0369152970922882,0.0277463570430501,CC,mono-sp-vs-hc
GO:0060205,cytoplasmic membrane-bounded vesicle lumen,60,0.521034931560491,1.85112065402853,0.00408163265306122,0.0369152970922882,0.0277463570430501,CC,mono-sp-vs-hc
GO:0005814,centriole,89,-0.397041074278142,-1.50559015483777,0.00409836065573771,0.0369152970922882,0.0277463570430501,CC,mono-sp-vs-hc
GO:0030139,endocytic vesicle,218,0.332384743233461,1.43009908026124,0.00409836065573771,0.0369152970922882,0.0277463570430501,CC,mono-sp-vs-hc
GO:0031983,vesicle lumen,61,0.53474209373894,1.9045642756686,0.00409836065573771,0.0369152970922882,0.0277463570430501,CC,mono-sp-vs-hc
GO:0005840,ribosome,209,-0.346726710553422,-1.46252951090036,0.00411522633744856,0.0369152970922882,0.0277463570430501,CC,mono-sp-vs-hc
GO:0005868,cytoplasmic dynein complex,15,-0.781329801557671,-2.03490636771023,0.004149377593361,0.0369152970922882,0.0277463570430501,CC,mono-sp-vs-hc
GO:0005643,nuclear pore,70,-0.497958451007669,-1.81364175053453,0.00420168067226891,0.0369152970922882,0.0277463570430501,CC,mono-sp-vs-hc
GO:0044450,microtubule organizing center part,129,-0.37017957829607,-1.47864026038876,0.00429184549356223,0.0369152970922882,0.0277463570430501,CC,mono-sp-vs-hc
GO:0000775,chromosome, centromeric region,169,-0.371091955229576,-1.53498958661811,0.00436681222707424,0.0369152970922882,0.0277463570430501,CC,mono-sp-vs-hc
GO:0005813,centrosome,447,-0.329457317639911,-1.51245861165302,0.00436681222707424,0.0369152970922882,0.0277463570430501,CC,mono-sp-vs-hc
GO:0030880,RNA polymerase complex,119,-0.396999786900237,-1.57979193981906,0.00442477876106195,0.0369152970922882,0.0277463570430501,CC,mono-sp-vs-hc
GO:0098687,chromosomal region,308,-0.326121316567834,-1.46642184237503,0.0045045045045045,0.0370511356426849,0.0278484563139863,CC,mono-sp-vs-hc
GO:0055038,recycling endosome membrane,39,0.582414777964357,1.82977224808565,0.0072463768115942,0.0561727504448612,0.0422206866177129,CC,mono-sp-vs-hc
GO:0043601,nuclear replisome,26,-0.549722997297447,-1.6242467575206,0.00743494423791822,0.0561727504448612,0.0422206866177129,CC,mono-sp-vs-hc
GO:0005938,cell cortex,202,0.33381064915898,1.40824423666186,0.00749063670411985,0.0561727504448612,0.0422206866177129,CC,mono-sp-vs-hc
GO:0030894,replisome,29,-0.559673461039642,-1.70138015229816,0.00760456273764259,0.0561727504448612,0.0422206866177129,CC,mono-sp-vs-hc
GO:0031091,platelet alpha granule,51,0.462869180554665,1.60331606362201,0.00772200772200772,0.0561727504448612,0.0422206866177129,CC,mono-sp-vs-hc
GO:0032587,ruffle membrane,69,0.433302094855176,1.55808229292768,0.00784313725490196,0.0561727504448612,0.0422206866177129,CC,mono-sp-vs-hc
GO:0061695,transferase complex, transferring phosphorus-containing groups,226,-0.30861856023526,-1.35726189995819,0.00784313725490196,0.0561727504448612,0.0422206866177129,CC,mono-sp-vs-hc
GO:0099568,cytoplasmic region,217,0.327204242432134,1.3844465137765,0.00784313725490196,0.0561727504448612,0.0422206866177129,CC,mono-sp-vs-hc
GO:0098802,plasma membrane receptor complex,126,0.385981790221701,1.54553633697504,0.00796812749003984,0.0561727504448612,0.0422206866177129,CC,mono-sp-vs-hc
GO:0000323,lytic vacuole,448,0.306487574518373,1.40429149408395,0.008,0.0561727504448612,0.0422206866177129,CC,mono-sp-vs-hc
GO:0005764,lysosome,448,0.306487574518373,1.40429149408395,0.008,0.0561727504448612,0.0422206866177129,CC,mono-sp-vs-hc
GO:0042599,lamellar body,13,0.713204957981815,1.72252076250716,0.00806451612903226,0.0561727504448612,0.0422206866177129,CC,mono-sp-vs-hc
GO:0000776,kinetochore,117,-0.404120481154472,-1.6063247010992,0.00813008130081301,0.0561727504448612,0.0422206866177129,CC,mono-sp-vs-hc
GO:0071013,catalytic step 2 spliceosome,85,-0.40419091140277,-1.51945043517136,0.00826446280991736,0.0561727504448612,0.0422206866177129,CC,mono-sp-vs-hc
GO:0000178,exosome (RNase complex),20,-0.615289187645123,-1.74095319900701,0.00829875518672199,0.0561727504448612,0.0422206866177129,CC,mono-sp-vs-hc
GO:0005759,mitochondrial matrix,369,-0.323206309354283,-1.45687716494734,0.00836820083682008,0.0561727504448612,0.0422206866177129,CC,mono-sp-vs-hc
GO:0000428,DNA-directed RNA polymerase complex,118,-0.392174663304908,-1.56013715546129,0.00881057268722467,0.0578131960599911,0.0434536819701087,CC,mono-sp-vs-hc
GO:0055029,nuclear DNA-directed RNA polymerase complex,118,-0.392174663304908,-1.56013715546129,0.00881057268722467,0.0578131960599911,0.0434536819701087,CC,mono-sp-vs-hc
GO:1901653,cellular response to peptide,431,0.367730148256814,1.67069098655966,0.00335570469798658,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:0002237,response to molecule of bacterial origin,284,0.384192842581699,1.68392629307224,0.00336700336700337,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:0071222,cellular response to lipopolysaccharide,139,0.463319589238499,1.86813185559774,0.00336700336700337,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:0002218,activation of innate immune response,271,0.340752030600277,1.4724181287699,0.00338983050847458,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:0032496,response to lipopolysaccharide,273,0.395556535696883,1.7228843338213,0.00338983050847458,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:0045088,regulation of innate immune response,361,0.33438409424881,1.48030222383899,0.00341296928327645,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:0032640,tumor necrosis factor production,94,0.428123511768854,1.59774696986032,0.00342465753424658,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:0050900,leukocyte migration,282,0.348461561844519,1.52646352272549,0.00342465753424658,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:0002758,innate immune response-activating signal transduction,265,0.351355408333066,1.51715537843453,0.00344827586206897,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:0031349,positive regulation of defense response,383,0.311940154208075,1.38113978978274,0.00346020761245675,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:0071706,tumor necrosis factor superfamily cytokine production,98,0.424947850892792,1.59048559751242,0.00346020761245675,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:0071216,cellular response to biotic stimulus,163,0.430835582182426,1.75315328893658,0.00348432055749129,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:0030198,extracellular matrix organization,247,0.432071686066881,1.87195382355128,0.00350877192982456,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:0032680,regulation of tumor necrosis factor production,93,0.43752209276596,1.61785295961755,0.00350877192982456,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:0071219,cellular response to molecule of bacterial origin,146,0.441049568165722,1.7778756644579,0.00350877192982456,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:0009617,response to bacterium,400,0.390743967339835,1.75039693888077,0.00352112676056338,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:0030260,entry into host cell,103,0.50230342581589,1.95325276826857,0.00352112676056338,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:0034110,regulation of homotypic cell-cell adhesion,268,0.349959330281964,1.52901834072158,0.00352112676056338,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:0043062,extracellular structure organization,248,0.42703068567677,1.85370763443856,0.00352112676056338,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:0044409,entry into host,103,0.50230342581589,1.95325276826857,0.00352112676056338,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:0051806,entry into cell of other organism involved in symbiotic interaction,103,0.50230342581589,1.95325276826857,0.00352112676056338,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:0051828,entry into other organism involved in symbiotic interaction,103,0.50230342581589,1.95325276826857,0.00352112676056338,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:0052126,movement in host environment,103,0.50230342581589,1.95325276826857,0.00352112676056338,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:0052192,movement in environment of other organism involved in symbiotic interaction,103,0.50230342581589,1.95325276826857,0.00352112676056338,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:0070486,leukocyte aggregation,389,0.34324215916721,1.55361607375812,0.00352112676056338,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:0046626,regulation of insulin receptor signaling pathway,40,0.517916461228372,1.70534152959233,0.00353356890459364,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:0032868,response to insulin,384,0.346869581372195,1.55510246482716,0.00354609929078014,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:0051091,positive regulation of sequence-specific DNA binding transcription factor activity,184,0.348393993900304,1.46704121530945,0.00354609929078014,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:0071375,cellular response to peptide hormone stimulus,416,0.360526686250133,1.62282594858174,0.00354609929078014,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:1902532,negative regulation of intracellular signal transduction,373,0.330675239631636,1.49262628370477,0.00354609929078014,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:0019730,antimicrobial humoral response,31,0.553257951051608,1.65598170379689,0.00355871886120996,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:0032869,cellular response to insulin stimulus,345,0.345894335708218,1.52523917879761,0.00355871886120996,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:2001243,negative regulation of intrinsic apoptotic signaling pathway,78,0.463424419555492,1.70862919385897,0.00355871886120996,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:0007159,leukocyte cell-cell adhesion,414,0.343231479474336,1.55584258088654,0.00357142857142857,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:0045912,negative regulation of carbohydrate metabolic process,38,0.610211329482759,1.94877543818017,0.00357142857142857,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:0046631,alpha-beta T cell activation,100,0.418609876263675,1.60777776326802,0.00357142857142857,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:0061061,muscle structure development,401,0.324635784981684,1.47621228943444,0.00357142857142857,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:0071496,cellular response to external stimulus,220,0.385704023674915,1.6412578647449,0.00357142857142857,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:0048514,blood vessel morphogenesis,368,0.358433454176173,1.62830283329401,0.003584229390681,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:0050863,regulation of T cell activation,253,0.348049169803866,1.50913374628892,0.003584229390681,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:0001525,angiogenesis,316,0.341334393570437,1.52187246637556,0.00359712230215827,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:0007599,hemostasis,462,0.421914993881105,1.92317262432467,0.00359712230215827,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:0015672,monovalent inorganic cation transport,379,0.327539922307699,1.46319616933114,0.00359712230215827,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:0042110,T cell activation,382,0.333921431716348,1.50603752321692,0.00359712230215827,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:0070489,T cell aggregation,382,0.333921431716348,1.50603752321692,0.00359712230215827,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:0071396,cellular response to lipid,417,0.338592487958915,1.53292570907181,0.00359712230215827,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:0071593,lymphocyte aggregation,383,0.332585021065141,1.49924603033609,0.00359712230215827,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:0002521,leukocyte differentiation,395,0.328569958576651,1.48070643315684,0.0036101083032491,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:0006691,leukotriene metabolic process,26,0.605988629186383,1.84008420046239,0.0036101083032491,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:0022407,regulation of cell-cell adhesion,320,0.368856193152558,1.64954527733326,0.0036101083032491,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:0042886,amide transport,265,0.376393753148944,1.62444517518777,0.0036101083032491,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:0046676,negative regulation of insulin secretion,33,0.548616533270724,1.71552217138958,0.0036101083032491,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:0071774,response to fibroblast growth factor,283,0.320375163893441,1.41138989760496,0.0036101083032491,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:0090087,regulation of peptide transport,204,0.391310233034878,1.6522895987613,0.0036101083032491,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:2001234,negative regulation of apoptotic signaling pathway,167,0.4091015516122,1.69886331299224,0.0036101083032491,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:0034146,toll-like receptor 5 signaling pathway,69,0.479397246614618,1.7116769359569,0.0036231884057971,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:0046718,viral entry into host cell,99,0.509491744540839,1.96638524569351,0.0036231884057971,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:0051090,regulation of sequence-specific DNA binding transcription factor activity,301,0.371973930571185,1.64760756718325,0.0036231884057971,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:0001944,vasculature development,459,0.3405996404511,1.57397921885472,0.00363636363636364,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:0015833,peptide transport,248,0.395711043500968,1.69676729940362,0.00363636363636364,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:0043434,response to peptide hormone,491,0.356687597639375,1.63078077548241,0.00363636363636364,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:0050817,coagulation,460,0.418587477749481,1.90270904042612,0.00363636363636364,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:0097285,cell-type specific apoptotic process,353,0.305545787044188,1.35847766853298,0.00363636363636364,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:0007596,blood coagulation,457,0.422988985292846,1.92178562079651,0.00364963503649635,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:0030099,myeloid cell differentiation,302,0.305953440675122,1.3590300770437,0.00364963503649635,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:0034166,toll-like receptor 10 signaling pathway,68,0.482422887070875,1.71186878405674,0.00364963503649635,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:0045649,regulation of macrophage differentiation,18,0.698708614251473,1.96697188805619,0.00364963503649635,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:0002694,regulation of leukocyte activation,380,0.321624942183694,1.43875808664192,0.00366300366300366,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:0008286,insulin receptor signaling pathway,291,0.340793428382848,1.48805245561967,0.00366300366300366,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:0010876,lipid localization,246,0.330616800138012,1.42830450000445,0.00366300366300366,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:0030073,insulin secretion,160,0.425017605405144,1.74864117460894,0.00366300366300366,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:0034142,toll-like receptor 4 signaling pathway,112,0.396028648786189,1.51491754759446,0.00366300366300366,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:0035666,TRIF-dependent toll-like receptor signaling pathway,80,0.42814152642408,1.58117606723142,0.00366300366300366,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:0043405,regulation of MAP kinase activity,394,0.332260689007691,1.49348769485579,0.00366300366300366,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:0044344,cellular response to fibroblast growth factor stimulus,279,0.323916019198454,1.41955377580875,0.00366300366300366,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:0050796,regulation of insulin secretion,140,0.441562360017006,1.78768566581576,0.00366300366300366,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:0070555,response to interleukin-1,92,0.471489477727458,1.79597106622005,0.00366300366300366,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:1902107,positive regulation of leukocyte differentiation,117,0.398364981399869,1.58558039998588,0.00366300366300366,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:1903034,regulation of response to wounding,304,0.338286567613514,1.48490972781191,0.00366300366300366,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:1903037,regulation of leukocyte cell-cell adhesion,260,0.34782584859446,1.5104966831256,0.00366300366300366,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:0006112,energy reserve metabolic process,136,0.393110359039895,1.60612174679381,0.00367647058823529,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:0032845,negative regulation of homeostatic process,145,0.375197396573694,1.51217745310547,0.00367647058823529,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:1903706,regulation of hemopoiesis,273,0.360826084701283,1.5840314357922,0.00367647058823529,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:0002286,T cell activation involved in immune response,67,0.467508754477233,1.71258776793937,0.003690036900369,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:0002761,regulation of myeloid leukocyte differentiation,91,0.461434849269503,1.74960181436842,0.003690036900369,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:0046632,alpha-beta T cell differentiation,74,0.479344246834074,1.75140169746832,0.003690036900369,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:0050865,regulation of cell activation,406,0.320202157473206,1.43646671454838,0.003690036900369,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:1901099,negative regulation of signal transduction in absence of ligand,24,0.591382922475154,1.69970033732547,0.003690036900369,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:1901655,cellular response to ketone,62,0.5241834250447,1.84625857589729,0.003690036900369,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:2001240,negative regulation of extrinsic apoptotic signaling pathway in absence of ligand,24,0.591382922475154,1.69970033732547,0.003690036900369,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:0001568,blood vessel development,439,0.340548208434212,1.5686619716832,0.0037037037037037,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:0002576,platelet degranulation,75,0.534115589974227,1.95016521222461,0.0037037037037037,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:0006818,hydrogen transport,124,0.446234413786693,1.76792679406157,0.0037037037037037,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:0007623,circadian rhythm,152,0.440480973886369,1.80203549234951,0.0037037037037037,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:0034330,cell junction organization,206,0.338837718484756,1.45186380984958,0.0037037037037037,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:0045619,regulation of lymphocyte differentiation,119,0.377658472804689,1.49441136067243,0.0037037037037037,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:0071347,cellular response to interleukin-1,68,0.482920313729394,1.75229116056921,0.0037037037037037,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:0090276,regulation of peptide hormone secretion,158,0.41166130921212,1.68131820328243,0.0037037037037037,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:0006091,generation of precursor metabolites and energy,394,0.35966359990677,1.63676507208543,0.00371747211895911,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:0006898,receptor-mediated endocytosis,213,0.349194057016811,1.48051651706998,0.00371747211895911,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:0032271,regulation of protein polymerization,151,0.385811097744779,1.57879187406687,0.00371747211895911,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:0071378,cellular response to growth hormone stimulus,28,0.610339087766372,1.82963538467603,0.00371747211895911,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:1903649,regulation of cytoplasmic transport,388,0.323633080797979,1.45289378781732,0.00371747211895911,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:2001233,regulation of apoptotic signaling pathway,333,0.354306196849936,1.57965865000506,0.00371747211895911,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:0008015,blood circulation,340,0.347173127231022,1.55099602225063,0.00373134328358209,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:0015980,energy derivation by oxidation of organic compounds,322,0.348141979343482,1.54991432639321,0.00373134328358209,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:0015992,proton transport,122,0.445010968705528,1.75455862864308,0.00373134328358209,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:0030168,platelet activation,220,0.505999000145609,2.1270493286543,0.00373134328358209,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:0032147,activation of protein kinase activity,385,0.334965650154395,1.51211857934137,0.00373134328358209,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:0034109,homotypic cell-cell adhesion,436,0.352992494710646,1.60290786893775,0.00373134328358209,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:0051258,protein polymerization,196,0.370134448889431,1.55814521596464,0.00373134328358209,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:0071902,positive regulation of protein serine/threonine kinase activity,248,0.368050960759332,1.58429011791748,0.00373134328358209,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:0002224,toll-like receptor signaling pathway,148,0.385513846699097,1.52638929993439,0.00374531835205993,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:0002573,myeloid leukocyte differentiation,165,0.37512312288611,1.54204710469681,0.00374531835205993,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:0009206,purine ribonucleoside triphosphate biosynthetic process,46,0.491737168776378,1.62760170904587,0.00374531835205993,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:0043410,positive regulation of MAPK cascade,478,0.329203536576245,1.49956380860628,0.00374531835205993,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:0045637,regulation of myeloid cell differentiation,156,0.36980868708978,1.51166279664016,0.00374531835205993,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:0045785,positive regulation of cell adhesion,305,0.361523735173282,1.59790048200742,0.00374531835205993,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:0048511,rhythmic process,241,0.415717375959102,1.80449972252969,0.00374531835205993,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:0051249,regulation of lymphocyte activation,332,0.333110921319155,1.47521665014367,0.00374531835205993,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:0060396,growth hormone receptor signaling pathway,27,0.618361644240026,1.84410915170626,0.00374531835205993,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:0071229,cellular response to acid chemical,136,0.403589640403041,1.63881451596343,0.00374531835205993,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:0097306,cellular response to alcohol,95,0.465084662225752,1.7390651092004,0.00374531835205993,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:0002449,lymphocyte mediated immunity,189,0.359741252371849,1.52341898716725,0.0037593984962406,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:0003013,circulatory system process,342,0.345484383431861,1.54232479189816,0.0037593984962406,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:0008631,intrinsic apoptotic signaling pathway in response to oxidative stress,41,0.526407351021043,1.73867961982946,0.0037593984962406,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:0009636,response to toxic substance,205,0.374490498648035,1.57817882144551,0.0037593984962406,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:0010677,negative regulation of cellular carbohydrate metabolic process,31,0.644294994220455,1.93039390034394,0.0037593984962406,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:0019048,modulation by virus of host morphology or physiology,61,-0.549423369471517,-1.99938929701023,0.0037593984962406,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:0019932,second-messenger-mediated signaling,177,0.388666353627354,1.63708615351314,0.0037593984962406,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:0030072,peptide hormone secretion,188,0.392021779234809,1.61795070368214,0.0037593984962406,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:0030100,regulation of endocytosis,165,0.353538308429929,1.45591828841964,0.0037593984962406,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:0050731,positive regulation of peptidyl-tyrosine phosphorylation,114,0.412622268499614,1.6047275529973,0.0037593984962406,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:0070372,regulation of ERK1 and ERK2 cascade,168,0.361542763184532,1.47927440075448,0.0037593984962406,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:1903708,positive regulation of hemopoiesis,144,0.372034962417238,1.5095396544314,0.0037593984962406,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:2000377,regulation of reactive oxygen species metabolic process,133,0.430577147410892,1.69630424579171,0.0037593984962406,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:0000186,activation of MAPKK activity,197,0.375533544958758,1.5866078010185,0.00377358490566038,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:0001101,response to acid chemical,243,0.357731340337735,1.53679201963862,0.00377358490566038,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:0006027,glycosaminoglycan catabolic process,42,0.492792044176106,1.59611347484825,0.00377358490566038,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:0006959,humoral immune response,121,0.443978358025277,1.75865739603359,0.00377358490566038,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:0010712,regulation of collagen metabolic process,31,0.585613104275378,1.82139314846732,0.00377358490566038,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:0035710,CD4-positive, alpha-beta T cell activation,58,0.587751555196432,2.05118477923232,0.00377358490566038,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:0043277,apoptotic cell clearance,26,0.569767838270006,1.70886398416322,0.00377358490566038,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:0071850,mitotic cell cycle arrest,13,0.665328730674894,1.7195306091883,0.00377358490566038,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:0072593,reactive oxygen species metabolic process,200,0.393650327223312,1.65431544412271,0.00377358490566038,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:1902105,regulation of leukocyte differentiation,202,0.403414200596487,1.69951815718928,0.00377358490566038,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:2001237,negative regulation of extrinsic apoptotic signaling pathway,75,0.435935585453299,1.60250650804101,0.00377358490566038,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:0002253,activation of immune response,472,0.325155982494279,1.47853633145525,0.00378787878787879,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:0002292,T cell differentiation involved in immune response,48,0.507499478564085,1.72783456223083,0.00378787878787879,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:0002757,immune response-activating signal transduction,433,0.32315862118093,1.45944019244419,0.00378787878787879,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:0007173,epidermal growth factor receptor signaling pathway,310,0.302127672310564,1.3399736864177,0.00378787878787879,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:0007411,axon guidance,427,0.338447092290179,1.5412314210651,0.00378787878787879,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:0009914,hormone transport,228,0.371741857468132,1.57362600771673,0.00378787878787879,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:0030316,osteoclast differentiation,72,0.461899034648365,1.68521591016221,0.00378787878787879,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:0030855,epithelial cell differentiation,381,0.304610860125486,1.37230431891827,0.00378787878787879,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:0034114,regulation of heterotypic cell-cell adhesion,15,0.774078756656302,2.01034995047686,0.00378787878787879,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:0034329,cell junction assembly,185,0.358389483058235,1.5107651129363,0.00378787878787879,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:0086065,cell communication involved in cardiac conduction,31,0.622250418356614,1.91413439591174,0.00378787878787879,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:0097305,response to alcohol,269,0.382817109286127,1.67556243460379,0.00378787878787879,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:0097485,neuron projection guidance,427,0.338447092290179,1.5412314210651,0.00378787878787879,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:0002287,alpha-beta T cell activation involved in immune response,43,0.571674698474646,1.89552481747634,0.00380228136882129,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:0002293,alpha-beta T cell differentiation involved in immune response,43,0.571674698474646,1.89552481747634,0.00380228136882129,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:0002294,CD4-positive, alpha-beta T cell differentiation involved in immune response,43,0.571674698474646,1.89552481747634,0.00380228136882129,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:0002683,negative regulation of immune system process,306,0.321048333312365,1.40769073502195,0.00380228136882129,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:0002791,regulation of peptide secretion,161,0.431084746033283,1.75551262412097,0.00380228136882129,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:0006754,ATP biosynthetic process,38,0.535865036319615,1.74471314950502,0.00380228136882129,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:0007229,integrin-mediated signaling pathway,77,0.487463869167041,1.77889839990839,0.00380228136882129,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:0042493,response to drug,336,0.3042439100608,1.34287274027375,0.00380228136882129,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:0043367,CD4-positive, alpha-beta T cell differentiation,52,0.551959082744381,1.8780434753979,0.00380228136882129,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:0046879,hormone secretion,223,0.373243525151608,1.57363035987864,0.00380228136882129,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:1900407,regulation of cellular response to oxidative stress,50,0.479109043353856,1.62313692347409,0.00380228136882129,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:2000514,regulation of CD4-positive, alpha-beta T cell activation,35,0.588117280201524,1.88801225574752,0.00380228136882129,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:2001236,regulation of extrinsic apoptotic signaling pathway,132,0.377618429159305,1.49086353326797,0.00380228136882129,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:0001501,skeletal system development,308,0.342651953009216,1.50155766890322,0.00381679389312977,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:0006897,endocytosis,497,0.351805699798103,1.61669340105741,0.00381679389312977,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:0007265,Ras protein signal transduction,397,0.358717426414365,1.61601503667878,0.00381679389312977,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:0010817,regulation of hormone levels,326,0.329226421115826,1.45050178842241,0.00381679389312977,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:0020027,hemoglobin metabolic process,15,0.722124157017011,1.87829993628874,0.00381679389312977,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:0031668,cellular response to extracellular stimulus,159,0.395472727992883,1.62597402488671,0.00381679389312977,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:0038095,Fc-epsilon receptor signaling pathway,264,0.361316939197139,1.56779266253024,0.00381679389312977,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:0043269,regulation of ion transport,386,0.332020500831404,1.4793971946056,0.00381679389312977,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:0044246,regulation of multicellular organismal metabolic process,32,0.560730750932012,1.76566447627215,0.00381679389312977,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:0046883,regulation of hormone secretion,191,0.388493237379491,1.61347952793892,0.00381679389312977,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:0051235,maintenance of location,240,0.379090617767338,1.62634529683446,0.00381679389312977,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:0098660,inorganic ion transmembrane transport,485,0.351827253158248,1.61443602657378,0.00381679389312977,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:0001510,RNA methylation,48,-0.584519698227711,-2.00973007303063,0.00383141762452107,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:0016049,cell growth,368,0.330564620937757,1.48669760608798,0.00383141762452107,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:0032970,regulation of actin filament-based process,254,0.357297960548931,1.54646140369137,0.00383141762452107,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:0034250,positive regulation of cellular amide metabolic process,92,0.401298335839892,1.50660528264994,0.00383141762452107,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:0035725,sodium ion transmembrane transport,76,0.456751997461683,1.68849076954146,0.00383141762452107,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:0070371,ERK1 and ERK2 cascade,178,0.360592139946452,1.4818186717776,0.00383141762452107,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:0071384,cellular response to corticosteroid stimulus,40,0.541102020026798,1.77731854783302,0.00383141762452107,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:0098655,cation transmembrane transport,485,0.369334326052219,1.69455548737486,0.00383141762452107,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:1901342,regulation of vasculature development,170,0.351151013719474,1.45909832374394,0.00383141762452107,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:0001558,regulation of cell growth,292,0.340637392304097,1.49423190667103,0.00384615384615385,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:0002431,Fc receptor mediated stimulatory signaling pathway,78,0.499312167982202,1.85653028613858,0.00384615384615385,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:0006140,regulation of nucleotide metabolic process,133,0.381271759727924,1.55224574671629,0.00384615384615385,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:0007160,cell-matrix adhesion,151,0.415056238698133,1.69594785341325,0.00384615384615385,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:0007568,aging,232,0.369147301149036,1.58022666330008,0.00384615384615385,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:0051051,negative regulation of transport,366,0.324608361075404,1.45367372789064,0.00384615384615385,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:0071385,cellular response to glucocorticoid stimulus,38,0.601904449888804,1.95012862513447,0.00384615384615385,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:0008360,regulation of cell shape,112,0.467251634126309,1.83505399969599,0.00386100386100386,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:0010644,cell communication by electrical coupling,20,0.607404310757836,1.71594575008343,0.00386100386100386,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:0019054,modulation by virus of host process,51,-0.598277441211232,-2.11830777000154,0.00386100386100386,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:0022408,negative regulation of cell-cell adhesion,115,0.427736912297469,1.67833293905236,0.00386100386100386,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:0042093,T-helper cell differentiation,41,0.577635326788664,1.87784186908469,0.00386100386100386,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:0051208,sequestering of calcium ion,86,0.453369051762075,1.70022252353986,0.00386100386100386,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:0060416,response to growth hormone,34,0.607282991496625,1.86175166160717,0.00386100386100386,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:0002433,immune response-regulating cell surface receptor signaling pathway involved in phagocytosis,72,0.505792584286843,1.85816395096368,0.00387596899224806,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:0002790,peptide secretion,193,0.408928588132561,1.68365032459991,0.00387596899224806,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:0007250,activation of NF-kappaB-inducing kinase activity,16,0.672412520618323,1.73732379330809,0.00387596899224806,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:0030323,respiratory tube development,144,0.372261358771947,1.51487841306312,0.00387596899224806,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:0031589,cell-substrate adhesion,232,0.412553556607756,1.76304257621011,0.00387596899224806,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:0038096,Fc-gamma receptor signaling pathway involved in phagocytosis,72,0.505792584286843,1.85816395096368,0.00387596899224806,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:0038127,ERBB signaling pathway,315,0.302518336296986,1.33811024712324,0.00387596899224806,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:0043370,regulation of CD4-positive, alpha-beta T cell differentiation,31,0.591496702361721,1.84104045136454,0.00387596899224806,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:0044003,modification by symbiont of host morphology or physiology,67,-0.529846130973918,-1.93886818046029,0.00387596899224806,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:0051209,release of sequestered calcium ion into cytosol,82,0.455796927565307,1.69975367710198,0.00387596899224806,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:0051283,negative regulation of sequestering of calcium ion,82,0.455796927565307,1.69975367710198,0.00387596899224806,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:1903510,mucopolysaccharide metabolic process,101,0.393566406793297,1.5356144134766,0.00387596899224806,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:0009205,purine ribonucleoside triphosphate metabolic process,194,0.355640980968819,1.50110557004034,0.00389105058365759,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:0009612,response to mechanical stimulus,161,0.378155936540492,1.55873630225845,0.00389105058365759,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:0022604,regulation of cell morphogenesis,403,0.350396747518889,1.60495537882507,0.00389105058365759,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:0033157,regulation of intracellular protein transport,323,0.330268123265299,1.45112072772163,0.00389105058365759,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:0048011,neurotrophin TRK receptor signaling pathway,345,0.354639655185997,1.57451851117771,0.00389105058365759,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:0051224,negative regulation of protein transport,173,0.403335844512832,1.68372181190126,0.00389105058365759,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:0051282,regulation of sequestering of calcium ion,83,0.455320252717027,1.7001521853595,0.00389105058365759,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:0060314,regulation of ryanodine-sensitive calcium-release channel activity,20,0.66212370779877,1.92569280027098,0.00389105058365759,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:0097193,intrinsic apoptotic signaling pathway,265,0.368972766699254,1.6173550359562,0.00389105058365759,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:0098754,detoxification,70,0.442746611022709,1.56932285651704,0.00389105058365759,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:1903828,negative regulation of cellular protein localization,124,0.364286952131074,1.44708136245004,0.00389105058365759,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:2001242,regulation of intrinsic apoptotic signaling pathway,133,0.438952310550401,1.75217503471872,0.00389105058365759,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:0001503,ossification,268,0.356008466383588,1.55045529716106,0.00390625,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:0014808,release of sequestered calcium ion into cytosol by sarcoplasmic reticulum,24,0.603058683106502,1.77735712856992,0.00390625,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:0016925,protein sumoylation,121,-0.432290692276052,-1.74800387583839,0.00390625,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:0032570,response to progesterone,35,0.663066617752964,2.11318423083071,0.00390625,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:0032956,regulation of actin cytoskeleton organization,229,0.341388272029346,1.45760932087828,0.00390625,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:0038094,Fc-gamma receptor signaling pathway,76,0.492967570700509,1.82954158921658,0.00390625,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:0051238,sequestering of metal ion,96,0.487163061343671,1.85595014681025,0.00390625,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:0070482,response to oxygen levels,253,0.359606851466489,1.56437157181924,0.00390625,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:0090670,RNA localization to Cajal body,16,-0.709457610172439,-1.8734430850315,0.00390625,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:0090671,telomerase RNA localization to Cajal body,16,-0.709457610172439,-1.8734430850315,0.00390625,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:0090672,telomerase RNA localization,16,-0.709457610172439,-1.8734430850315,0.00390625,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:0098662,inorganic cation transmembrane transport,444,0.357519462130782,1.62709702379248,0.00390625,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:1902175,regulation of oxidative stress-induced intrinsic apoptotic signaling pathway,26,0.633545347510241,1.8346973486223,0.00390625,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:1903514,calcium ion transport from endoplasmic reticulum to cytosol,24,0.603058683106502,1.77735712856992,0.00390625,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:1903533,regulation of protein targeting,256,0.340186577222589,1.46343314898139,0.00390625,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:0001666,response to hypoxia,232,0.372733774657612,1.61530226187054,0.00392156862745098,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:0010880,regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum,20,0.645752675474848,1.80532375406253,0.00392156862745098,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:0038179,neurotrophin signaling pathway,347,0.355667228423433,1.57982955444167,0.00392156862745098,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:0042769,DNA damage response, detection of DNA damage,36,-0.616884278958965,-2.00463968766207,0.00392156862745098,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:0043491,protein kinase B signaling,117,0.420345349691462,1.65220908663299,0.00392156862745098,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:0044068,modulation by symbiont of host cellular process,54,-0.571783487963533,-2.0271728002469,0.00392156862745098,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:0061337,cardiac conduction,88,0.419028939636923,1.57789246286582,0.00392156862745098,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:2000021,regulation of ion homeostasis,141,0.382170996821925,1.55415990869148,0.00392156862745098,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:0001678,cellular glucose homeostasis,101,0.405800094945652,1.56362804938664,0.00393700787401575,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:0008154,actin polymerization or depolymerization,156,0.370315850200432,1.51425678791881,0.00393700787401575,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:0008361,regulation of cell size,137,0.34381196624723,1.40835075782454,0.00393700787401575,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:0009199,ribonucleoside triphosphate metabolic process,200,0.346128140521923,1.46119374559583,0.00393700787401575,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:0032922,circadian regulation of gene expression,51,0.551733231275103,1.8843466001302,0.00393700787401575,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:0044259,multicellular organismal macromolecule metabolic process,74,0.451374087620897,1.67887959275535,0.00393700787401575,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:0044724,single-organism carbohydrate catabolic process,114,0.356320323648879,1.42040107929139,0.00393700787401575,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:0048598,embryonic morphogenesis,397,0.328385140468444,1.47914291598172,0.00393700787401575,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:0051926,negative regulation of calcium ion transport,32,0.596912570496443,1.86966696069887,0.00393700787401575,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:0060326,cell chemotaxis,177,0.351342635643146,1.45284484343924,0.00393700787401575,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:0006163,purine nucleotide metabolic process,394,0.307005723665411,1.39742021525856,0.00395256916996047,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:0032963,collagen metabolic process,71,0.474998823248808,1.75754472838006,0.00395256916996047,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:0038093,Fc receptor signaling pathway,320,0.372916359753324,1.64683357146704,0.00395256916996047,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:0045666,positive regulation of neuron differentiation,217,0.343237758219695,1.47613921310281,0.00395256916996047,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:0045927,positive regulation of growth,178,0.347201362207236,1.44109778963818,0.00395256916996047,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:0048013,ephrin receptor signaling pathway,80,0.454573154529654,1.66758471745501,0.00395256916996047,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:0051349,positive regulation of lyase activity,27,0.570728530606377,1.76081845038276,0.00395256916996047,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:0051924,regulation of calcium ion transport,148,0.411877242693823,1.67733583855963,0.00395256916996047,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:0006998,nuclear envelope organization,71,-0.454736833267066,-1.68309233105491,0.00396825396825397,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:0019229,regulation of vasoconstriction,42,0.530963449565104,1.72165076541998,0.00396825396825397,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:0030278,regulation of ossification,131,0.386749219323042,1.55266096998029,0.00396825396825397,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:0031344,regulation of cell projection organization,395,0.335840882583988,1.52283108359898,0.00396825396825397,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:0031346,positive regulation of cell projection organization,231,0.357809046627805,1.5603166350809,0.00396825396825397,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:0033619,membrane protein proteolysis,49,0.549714050034704,1.86155748909603,0.00396825396825397,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:0033683,nucleotide-excision repair, DNA incision,39,-0.609462971214237,-1.96645678486809,0.00396825396825397,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:0048708,astrocyte differentiation,48,0.462831234295943,1.57343523482537,0.00396825396825397,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:1901654,response to ketone,138,0.455100461397815,1.85106716265509,0.00396825396825397,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:1904031,positive regulation of cyclin-dependent protein kinase activity,32,0.632360700434277,1.95330818906577,0.00396825396825397,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:2001244,positive regulation of intrinsic apoptotic signaling pathway,54,0.480586445098203,1.67321039976092,0.00396825396825397,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:0002768,immune response-regulating cell surface receptor signaling pathway,451,0.335836707719213,1.53020935612868,0.00398406374501992,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:0008064,regulation of actin polymerization or depolymerization,136,0.359759301184967,1.43957093407387,0.00398406374501992,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:0008380,RNA splicing,353,-0.304538819686811,-1.39051176735025,0.00398406374501992,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:0009259,ribonucleotide metabolic process,388,0.311854518630953,1.41309514061785,0.00398406374501992,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:0019693,ribose phosphate metabolic process,400,0.308397687094366,1.40092427735882,0.00398406374501992,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:0019885,antigen processing and presentation of endogenous peptide antigen via MHC class I,14,0.677833876465902,1.7457133491617,0.00398406374501992,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:0030029,actin filament-based process,498,0.338278625331002,1.55359218422375,0.00398406374501992,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:0034113,heterotypic cell-cell adhesion,38,0.681703667178665,2.20326895403648,0.00398406374501992,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:0045664,regulation of neuron differentiation,389,0.346385488218765,1.5611627226626,0.00398406374501992,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:0071243,cellular response to arsenic-containing substance,14,0.827126877935891,2.11595953930247,0.00398406374501992,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:0086064,cell communication by electrical coupling involved in cardiac conduction,18,0.647614049212116,1.76183906942563,0.00398406374501992,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:1903409,reactive oxygen species biosynthetic process,75,0.436689240146698,1.61844028952416,0.00398406374501992,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:0000375,RNA splicing, via transesterification reactions,269,-0.306208348025858,-1.35885739341091,0.004,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:0006399,tRNA metabolic process,190,-0.466432354744805,-1.94115533746367,0.004,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:0009150,purine ribonucleotide metabolic process,374,0.316724257590154,1.43258930144588,0.004,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:0018212,peptidyl-tyrosine modification,251,0.33012272839807,1.42389199675175,0.004,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:0035821,modification of morphology or physiology of other organism,113,-0.397271555212394,-1.57487808335636,0.004,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:0048010,vascular endothelial growth factor receptor signaling pathway,254,0.408852999734188,1.76706882512793,0.004,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:0048732,gland development,330,0.326012808223875,1.44725229998806,0.004,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:0050801,ion homeostasis,494,0.325725742221624,1.49268639086655,0.004,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:0060713,labyrinthine layer morphogenesis,19,0.679159555919919,1.86236807441449,0.004,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:1903426,regulation of reactive oxygen species biosynthetic process,58,0.434729923967488,1.54252337127864,0.004,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:1904872,regulation of telomerase RNA localization to Cajal body,15,-0.725176513754165,-1.89139758788136,0.004,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:1904874,positive regulation of telomerase RNA localization to Cajal body,15,-0.725176513754165,-1.89139758788136,0.004,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:1904950,negative regulation of establishment of protein localization,182,0.40914174882088,1.71683193192452,0.004,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:2001057,reactive nitrogen species metabolic process,70,0.462745483568184,1.70525644511424,0.004,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:0006509,membrane protein ectodomain proteolysis,35,0.554540919016559,1.73586057722967,0.00401606425702811,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:0007422,peripheral nervous system development,51,0.516682718766861,1.74638986556177,0.00401606425702811,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:0010959,regulation of metal ion transport,230,0.396199490766808,1.66344338106853,0.00401606425702811,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:0030832,regulation of actin filament length,137,0.357025656321923,1.42963905709859,0.00401606425702811,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:0034383,low-density lipoprotein particle clearance,15,0.723104316138001,1.84165064442293,0.00401606425702811,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:0040008,regulation of growth,490,0.342748545642144,1.56096019746712,0.00401606425702811,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:0097006,regulation of plasma lipoprotein particle levels,44,0.547585107070226,1.76919905844705,0.00401606425702811,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:1900026,positive regulation of substrate adhesion-dependent cell spreading,23,0.631509049546819,1.83416014664634,0.00401606425702811,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:1901222,regulation of NIK/NF-kappaB signaling,36,0.519999204203119,1.63550425837605,0.00401606425702811,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:0006909,phagocytosis,188,0.450583029614309,1.90463196480331,0.00403225806451613,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:0010470,regulation of gastrulation,23,0.685588149575445,1.91008737942577,0.00403225806451613,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:0010975,regulation of neuron projection development,291,0.340494144275434,1.50479370166602,0.00403225806451613,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:0018108,peptidyl-tyrosine phosphorylation,249,0.321766079404347,1.38551764158119,0.00403225806451613,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:0035637,multicellular organismal signaling,119,0.389793692836014,1.52873756273801,0.00403225806451613,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:0036003,positive regulation of transcription from RNA polymerase II promoter in response to stress,20,0.688236802688601,1.91784937007382,0.00403225806451613,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:0046034,ATP metabolic process,181,0.355434116635995,1.48858541511355,0.00403225806451613,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:0048638,regulation of developmental growth,219,0.340355749922736,1.45646997228556,0.00403225806451613,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:0051043,regulation of membrane protein ectodomain proteolysis,17,0.735267460518396,1.91848281500406,0.00403225806451613,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:0051384,response to glucocorticoid,118,0.445831115221792,1.76349905302196,0.00403225806451613,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:0051385,response to mineralocorticoid,23,0.590597101217673,1.74508299890765,0.00403225806451613,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:0051928,positive regulation of calcium ion transport,73,0.433436956882479,1.57548327876794,0.00403225806451613,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:0055080,cation homeostasis,443,0.327150595201722,1.48887268838466,0.00403225806451613,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:0090279,regulation of calcium ion import,70,0.53263583033609,1.89126992514602,0.00403225806451613,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:1902600,hydrogen ion transmembrane transport,89,0.488530793370659,1.81744593946544,0.00403225806451613,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:1903707,negative regulation of hemopoiesis,106,0.402878623452299,1.5748448326938,0.00403225806451613,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:0031960,response to corticosteroid,123,0.426291461317988,1.69794458746475,0.00404858299595142,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:0044236,multicellular organism metabolic process,84,0.407661011295553,1.54518124739643,0.00404858299595142,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:0045737,positive regulation of cyclin-dependent protein serine/threonine kinase activity,30,0.619096435241696,1.87837705744301,0.00404858299595142,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:0050727,regulation of inflammatory response,218,0.35812605513569,1.51159019814078,0.00404858299595142,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:0050767,regulation of neurogenesis,470,0.306519861416277,1.39899419878899,0.00404858299595142,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:0060411,cardiac septum morphogenesis,30,0.576954960991137,1.78078817864581,0.00404858299595142,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:0071453,cellular response to oxygen levels,123,0.406249740257073,1.63164478622439,0.00404858299595142,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:0072521,purine-containing compound metabolic process,432,0.283738739499187,1.29693334121183,0.00404858299595142,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:0098771,inorganic ion homeostasis,452,0.335924737984221,1.52677862047373,0.00404858299595142,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:1901224,positive regulation of NIK/NF-kappaB signaling,27,0.60805441702599,1.80107548940515,0.00404858299595142,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:1902106,negative regulation of leukocyte differentiation,65,0.47938592504638,1.73398517571013,0.00404858299595142,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:0002455,humoral immune response mediated by circulating immunoglobulin,39,0.573549263825756,1.88604157905509,0.0040650406504065,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:0006999,nuclear pore organization,13,-0.726425833217884,-1.85622474444287,0.0040650406504065,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:0007009,plasma membrane organization,225,0.369936115038251,1.58167935417613,0.0040650406504065,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:0010976,positive regulation of neuron projection development,170,0.345925618488681,1.45239925482467,0.0040650406504065,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:0034381,plasma lipoprotein particle clearance,24,0.704703492537838,1.99806964165851,0.0040650406504065,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:0046209,nitric oxide metabolic process,66,0.473226608046472,1.72333443809844,0.0040650406504065,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:0051412,response to corticosterone,19,0.631169264582322,1.80887434015669,0.0040650406504065,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:0060674,placenta blood vessel development,24,0.629163478592377,1.86278637944434,0.0040650406504065,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:0061448,connective tissue development,150,0.389972721500206,1.57225503229182,0.0040650406504065,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:0097553,calcium ion transmembrane import into cytosol,84,0.449844889362557,1.66642066170658,0.0040650406504065,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:1902656,calcium ion import into cytosol,84,0.449844889362557,1.66642066170658,0.0040650406504065,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:1903779,regulation of cardiac conduction,50,0.551732354130443,1.86344510137033,0.0040650406504065,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:0006310,DNA recombination,264,-0.316457765016265,-1.402653525881,0.00408163265306122,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:0030036,actin cytoskeleton organization,439,0.339673221120808,1.53970469894318,0.00408163265306122,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:0030397,membrane disassembly,45,-0.548106128213088,-1.85848681165997,0.00408163265306122,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:0031167,rRNA methylation,16,-0.790207148257118,-2.12356601452765,0.00408163265306122,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:0036294,cellular response to decreased oxygen levels,116,0.423606952213379,1.69021037156835,0.00408163265306122,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:0051081,nuclear envelope disassembly,45,-0.548106128213088,-1.85848681165997,0.00408163265306122,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:0008033,tRNA processing,140,-0.467757530540751,-1.8465846064795,0.00409836065573771,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:0045324,late endosome to vacuole transport,13,-0.724566446030242,-1.77493735695365,0.00409836065573771,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:0051591,response to cAMP,72,0.46714413169281,1.68177776971882,0.00409836065573771,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:0055065,metal ion homeostasis,406,0.332326768977163,1.49934050320629,0.00409836065573771,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:0001763,morphogenesis of a branching structure,135,0.384237157985498,1.54111907646968,0.00411522633744856,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:0002526,acute inflammatory response,104,0.429163282168821,1.62344708783078,0.00411522633744856,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:0050769,positive regulation of neurogenesis,268,0.313440156048595,1.37546827011611,0.00411522633744856,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:0061180,mammary gland epithelium development,54,0.503382392050512,1.72476367197844,0.00411522633744856,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:0070509,calcium ion import,113,0.464167014205665,1.78934244393915,0.00411522633744856,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:0071456,cellular response to hypoxia,109,0.470290503849032,1.86374463224535,0.00411522633744856,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:0090501,RNA phosphodiester bond hydrolysis,103,-0.437354598585494,-1.73585601871217,0.00411522633744856,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:1900034,regulation of cellular response to heat,70,-0.431626763021253,-1.59366783799016,0.00411522633744856,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:0007015,actin filament organization,261,0.355931704768349,1.53459304121339,0.00413223140495868,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:0007052,mitotic spindle organization,75,-0.465561720339855,-1.72181458877317,0.00413223140495868,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:0008637,apoptotic mitochondrial changes,109,0.406126637066931,1.59786504727265,0.00413223140495868,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:0051279,regulation of release of sequestered calcium ion into cytosol,54,0.518375094147257,1.75770652760399,0.00413223140495868,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:1904816,positive regulation of protein localization to chromosome, telomeric region,12,-0.736239914310054,-1.77006275577862,0.00413223140495868,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:0006816,calcium ion transport,266,0.363196721478006,1.56409584784125,0.004149377593361,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:0007077,mitotic nuclear envelope disassembly,43,-0.541156108059679,-1.80929247025103,0.004149377593361,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:0048589,developmental growth,429,0.305785222298527,1.40294875434726,0.004149377593361,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:0051817,modification of morphology or physiology of other organism involved in symbiotic interaction,106,-0.413441033692874,-1.61230331422661,0.004149377593361,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:0090066,regulation of anatomical structure size,365,0.331983342948474,1.49622402481295,0.004149377593361,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:1903522,regulation of blood circulation,196,0.382907382587709,1.6158641686136,0.004149377593361,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:0006997,nucleus organization,117,-0.418553248525727,-1.67920958512547,0.00416666666666667,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:0009451,RNA modification,116,-0.484131581099576,-1.9120959936536,0.00416666666666667,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:0044786,cell cycle DNA replication,48,-0.537724650197042,-1.81204198703713,0.00416666666666667,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:0070911,global genome nucleotide-excision repair,62,-0.509631165076715,-1.78082379104049,0.00416666666666667,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:0071826,ribonucleoprotein complex subunit organization,196,-0.356537171569432,-1.50482752552924,0.00416666666666667,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:0006284,base-excision repair,49,-0.540846500105296,-1.85722092429877,0.00418410041841004,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:0022618,ribonucleoprotein complex assembly,187,-0.351636766214874,-1.46711116696863,0.00418410041841004,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:0043627,response to estrogen,161,0.344943622902334,1.43061544803423,0.00418410041841004,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:0055082,cellular chemical homeostasis,497,0.336420375412912,1.53978768556355,0.00418410041841004,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:0003015,heart process,173,0.357928541561138,1.47502228046007,0.00420168067226891,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:0006397,mRNA processing,413,-0.306518358222484,-1.41453445572742,0.00420168067226891,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:0006873,cellular ion homeostasis,398,0.333449217318779,1.50414360496348,0.00420168067226891,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:0032535,regulation of cellular component size,280,0.33134631658861,1.46500867842228,0.00420168067226891,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:0050890,cognition,175,0.343090263611207,1.43644938597218,0.00420168067226891,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:0022616,DNA strand elongation,43,-0.59261533664629,-1.94677313914076,0.00421940928270042,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:0007051,spindle organization,121,-0.408645924862906,-1.62866129374728,0.00423728813559322,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:0042273,ribosomal large subunit biogenesis,41,-0.552133692361161,-1.81811986594896,0.00423728813559322,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:0050849,negative regulation of calcium-mediated signaling,16,0.702460390302485,1.91996272565529,0.00423728813559322,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:0000722,telomere maintenance via recombination,30,-0.614083871787914,-1.91300156728297,0.00425531914893617,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:0000154,rRNA modification,20,-0.782439190566116,-2.1944751523948,0.00427350427350427,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:0002707,negative regulation of lymphocyte mediated immunity,29,0.563650728778935,1.71331856657821,0.00427350427350427,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:0010522,regulation of calcium ion transport into cytosol,66,0.466220602589614,1.64469483092617,0.00427350427350427,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:0016072,rRNA metabolic process,154,-0.52125432181954,-2.15585195449746,0.00427350427350427,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:0034660,ncRNA metabolic process,452,-0.428739820960217,-1.98418778857634,0.00427350427350427,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:0044057,regulation of system process,337,0.336190853170652,1.4875765528217,0.00429184549356223,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:0000460,maturation of 5.8S rRNA,22,-0.654416501105093,-1.90532612222008,0.00431034482758621,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:0006364,rRNA processing,150,-0.528096990864053,-2.17927738484351,0.00431034482758621,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:0043620,regulation of DNA-templated transcription in response to stress,61,0.543041561093459,1.91079522762786,0.00431034482758621,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:0007067,mitotic nuclear division,387,-0.329787725180511,-1.49372369789593,0.00432900432900433,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:0071426,ribonucleoprotein complex export from nucleus,88,-0.491324561033924,-1.87723049090658,0.00432900432900433,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:0006403,RNA localization,184,-0.408351954588322,-1.69295084634735,0.00434782608695652,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:0006415,translational termination,177,-0.373914351006577,-1.55307367316739,0.00434782608695652,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:0006637,acyl-CoA metabolic process,76,-0.414972115175948,-1.55164267774204,0.00434782608695652,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:0035383,thioester metabolic process,76,-0.414972115175948,-1.55164267774204,0.00434782608695652,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:0043508,negative regulation of JUN kinase activity,11,-0.727257985949956,-1.76048497272878,0.00434782608695652,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:0050657,nucleic acid transport,151,-0.392904130200165,-1.60156071242817,0.00434782608695652,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:0050658,RNA transport,151,-0.392904130200165,-1.60156071242817,0.00434782608695652,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:0071166,ribonucleoprotein complex localization,91,-0.492138596919566,-1.88832291004784,0.00434782608695652,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:0000280,nuclear division,474,-0.316348421580379,-1.45969414763142,0.00436681222707424,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:0043618,regulation of transcription from RNA polymerase II promoter in response to stress,57,0.541376593313901,1.88895837730722,0.00436681222707424,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:0070202,regulation of establishment of protein localization to chromosome,11,-0.746328394738532,-1.74860623477619,0.00436681222707424,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:0006312,mitotic recombination,41,-0.545213402236239,-1.7536682289137,0.0043859649122807,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:0034470,ncRNA processing,318,-0.471691217676209,-2.08250023493335,0.0043859649122807,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:0006405,RNA export from nucleus,90,-0.459539567186747,-1.74225486393597,0.00440528634361234,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:0051028,mRNA transport,126,-0.412444830870837,-1.63755794028612,0.00440528634361234,0.0500489476260401,0.0384711166069849,BP,mono-sp-vs-hc
GO:0010833,telomere maintenance via telomere lengthening,80,-0.476435178224684,-1.77527746490344,0.00444444444444444,0.0502446714850228,0.0386215636345219,BP,mono-sp-vs-hc
GO:0006414,translational elongation,203,-0.366932173875137,-1.55548075220685,0.00446428571428571,0.0502446714850228,0.0386215636345219,BP,mono-sp-vs-hc
GO:0015931,nucleobase-containing compound transport,179,-0.371471742657754,-1.53215385100239,0.00448430493273543,0.0502446714850228,0.0386215636345219,BP,mono-sp-vs-hc
GO:0042254,ribosome biogenesis,224,-0.529078525790702,-2.29021850714366,0.00448430493273543,0.0502446714850228,0.0386215636345219,BP,mono-sp-vs-hc
GO:0070925,organelle assembly,493,-0.310388285325931,-1.43090224130129,0.00448430493273543,0.0502446714850228,0.0386215636345219,BP,mono-sp-vs-hc
GO:0090305,nucleic acid phosphodiester bond hydrolysis,229,-0.424521519049705,-1.82612413576965,0.00448430493273543,0.0502446714850228,0.0386215636345219,BP,mono-sp-vs-hc
GO:0051236,establishment of RNA localization,154,-0.392783280988911,-1.59186083253053,0.0045045045045045,0.0502446714850228,0.0386215636345219,BP,mono-sp-vs-hc
GO:0070124,mitochondrial translational initiation,84,-0.574337619835031,-2.17064483101499,0.0045045045045045,0.0502446714850228,0.0386215636345219,BP,mono-sp-vs-hc
GO:0006406,mRNA export from nucleus,76,-0.482087654654275,-1.78212806110476,0.00452488687782805,0.0502446714850228,0.0386215636345219,BP,mono-sp-vs-hc
GO:0071427,mRNA-containing ribonucleoprotein complex export from nucleus,76,-0.482087654654275,-1.78212806110476,0.00452488687782805,0.0502446714850228,0.0386215636345219,BP,mono-sp-vs-hc
GO:0070125,mitochondrial translational elongation,84,-0.55920257486406,-2.1184325376142,0.00454545454545455,0.0503591216909501,0.0387095380560986,BP,mono-sp-vs-hc
GO:0022613,ribonucleoprotein complex biogenesis,361,-0.461421892403247,-2.08283095637788,0.00460829493087558,0.0508258685859266,0.0390683123175826,BP,mono-sp-vs-hc
GO:0070126,mitochondrial translational termination,86,-0.564311487815231,-2.1176889136615,0.00460829493087558,0.0508258685859266,0.0390683123175826,BP,mono-sp-vs-hc
GO:0032543,mitochondrial translation,113,-0.491045600561377,-1.94373717411219,0.00465116279069767,0.0511836479299197,0.0393433265089933,BP,mono-sp-vs-hc
hsa04510,Focal adhesion,156,0.428620908354093,1.75313120535318,0.00357142857142857,0.0206019871420222,0.0117659724999231,KG,mono-sp-vs-hc
hsa05203,Viral carcinogenesis,188,0.408027210300762,1.71210103825234,0.0036231884057971,0.0206019871420222,0.0117659724999231,KG,mono-sp-vs-hc
hsa00190,Oxidative phosphorylation,110,0.441482267194533,1.73480239877291,0.00363636363636364,0.0206019871420222,0.0117659724999231,KG,mono-sp-vs-hc
hsa04810,Regulation of actin cytoskeleton,166,0.471155313958803,1.92842889371059,0.00363636363636364,0.0206019871420222,0.0117659724999231,KG,mono-sp-vs-hc
hsa05205,Proteoglycans in cancer,165,0.36226020091925,1.46729500872792,0.00364963503649635,0.0206019871420222,0.0117659724999231,KG,mono-sp-vs-hc
hsa04151,PI3K-Akt signaling pathway,245,0.32338374242262,1.38405962407775,0.00366300366300366,0.0206019871420222,0.0117659724999231,KG,mono-sp-vs-hc
hsa04020,Calcium signaling pathway,124,0.387378539016927,1.51938211143065,0.00367647058823529,0.0206019871420222,0.0117659724999231,KG,mono-sp-vs-hc
hsa04932,Non-alcoholic fatty liver disease (NAFLD),138,0.396621812124448,1.60123790288094,0.00367647058823529,0.0206019871420222,0.0117659724999231,KG,mono-sp-vs-hc
hsa05100,Bacterial invasion of epithelial cells,70,0.479792738371929,1.74354732219797,0.00367647058823529,0.0206019871420222,0.0117659724999231,KG,mono-sp-vs-hc
hsa05206,MicroRNAs in cancer,132,0.395973316103442,1.5876314011973,0.00367647058823529,0.0206019871420222,0.0117659724999231,KG,mono-sp-vs-hc
hsa05012,Parkinson's disease,112,0.44909969681689,1.77848153082816,0.003690036900369,0.0206019871420222,0.0117659724999231,KG,mono-sp-vs-hc
hsa04014,Ras signaling pathway,166,0.382695415899006,1.59739521923374,0.0037037037037037,0.0206019871420222,0.0117659724999231,KG,mono-sp-vs-hc
hsa04514,Cell adhesion molecules (CAMs),111,0.453503185454731,1.81144655086281,0.00371747211895911,0.0206019871420222,0.0117659724999231,KG,mono-sp-vs-hc
hsa04010,MAPK signaling pathway,201,0.414694553655721,1.77397639541453,0.00374531835205993,0.0206019871420222,0.0117659724999231,KG,mono-sp-vs-hc
hsa05412,Arrhythmogenic right ventricular cardiomyopathy (ARVC),56,0.504453330259588,1.76371224930491,0.0037593984962406,0.0206019871420222,0.0117659724999231,KG,mono-sp-vs-hc
hsa04540,Gap junction,64,0.471932233644861,1.71753351671297,0.00378787878787879,0.0206019871420222,0.0117659724999231,KG,mono-sp-vs-hc
hsa05322,Systemic lupus erythematosus,108,0.477782173067889,1.87580657855581,0.00381679389312977,0.0206019871420222,0.0117659724999231,KG,mono-sp-vs-hc
hsa04728,Dopaminergic synapse,94,0.515140944562054,1.97356108713849,0.00383141762452107,0.0206019871420222,0.0117659724999231,KG,mono-sp-vs-hc
hsa04024,cAMP signaling pathway,140,0.442933497594225,1.79306990601296,0.00384615384615385,0.0206019871420222,0.0117659724999231,KG,mono-sp-vs-hc
hsa04917,Prolactin signaling pathway,62,0.486171585232272,1.69196058856385,0.00386100386100386,0.0206019871420222,0.0117659724999231,KG,mono-sp-vs-hc
hsa05016,Huntington's disease,166,0.433959596125638,1.80551556269716,0.00386100386100386,0.0206019871420222,0.0117659724999231,KG,mono-sp-vs-hc
hsa05152,Tuberculosis,153,0.427086844806328,1.75364351749059,0.00386100386100386,0.0206019871420222,0.0117659724999231,KG,mono-sp-vs-hc
hsa04015,Rap1 signaling pathway,163,0.431820868727003,1.77902405094122,0.00387596899224806,0.0206019871420222,0.0117659724999231,KG,mono-sp-vs-hc
hsa05010,Alzheimer's disease,147,0.412594996889728,1.6629875257097,0.00387596899224806,0.0206019871420222,0.0117659724999231,KG,mono-sp-vs-hc
hsa05145,Toxoplasmosis,109,0.435454871944867,1.70615127786939,0.00387596899224806,0.0206019871420222,0.0117659724999231,KG,mono-sp-vs-hc
hsa04720,Long-term potentiation,52,0.568349798672051,1.96161610140044,0.00389105058365759,0.0206019871420222,0.0117659724999231,KG,mono-sp-vs-hc
hsa05130,Pathogenic Escherichia coli infection,46,0.505527531919243,1.71275459923487,0.00389105058365759,0.0206019871420222,0.0117659724999231,KG,mono-sp-vs-hc
hsa05160,Hepatitis C,103,0.398192901004095,1.53738305538647,0.00389105058365759,0.0206019871420222,0.0117659724999231,KG,mono-sp-vs-hc
hsa04062,Chemokine signaling pathway,156,0.465492331847046,1.89702734024502,0.00390625,0.0206019871420222,0.0117659724999231,KG,mono-sp-vs-hc
hsa04725,Cholinergic synapse,81,0.462752795687735,1.74044902049708,0.00390625,0.0206019871420222,0.0117659724999231,KG,mono-sp-vs-hc
hsa04915,Estrogen signaling pathway,84,0.40519449746213,1.56255652309201,0.00392156862745098,0.0206019871420222,0.0117659724999231,KG,mono-sp-vs-hc
hsa04723,Retrograde endocannabinoid signaling,62,0.515709497831397,1.84635411534034,0.00396825396825397,0.0206019871420222,0.0117659724999231,KG,mono-sp-vs-hc
hsa04726,Serotonergic synapse,72,0.483814344317011,1.77946694964049,0.00396825396825397,0.0206019871420222,0.0117659724999231,KG,mono-sp-vs-hc
hsa04730,Long-term depression,48,0.502091093614523,1.7229518677379,0.00396825396825397,0.0206019871420222,0.0117659724999231,KG,mono-sp-vs-hc
hsa05034,Alcoholism,132,0.538368835863896,2.15909772356826,0.00398406374501992,0.0206019871420222,0.0117659724999231,KG,mono-sp-vs-hc
hsa05202,Transcriptional misregulation in cancer,147,0.425283916690557,1.76624234016843,0.00398406374501992,0.0206019871420222,0.0117659724999231,KG,mono-sp-vs-hc
hsa04210,Apoptosis,131,0.38766356392212,1.57137636373,0.004,0.0206019871420222,0.0117659724999231,KG,mono-sp-vs-hc
hsa04611,Platelet activation,103,0.444895133443961,1.74129956868007,0.004,0.0206019871420222,0.0117659724999231,KG,mono-sp-vs-hc
hsa04670,Leukocyte transendothelial migration,93,0.462668712169865,1.78042095115745,0.004,0.0206019871420222,0.0117659724999231,KG,mono-sp-vs-hc
hsa05164,Influenza A,149,0.360175642278562,1.48186763144299,0.004,0.0206019871420222,0.0117659724999231,KG,mono-sp-vs-hc
hsa04022,cGMP-PKG signaling pathway,125,0.409851917786999,1.64477440325055,0.00403225806451613,0.0206019871420222,0.0117659724999231,KG,mono-sp-vs-hc
hsa04380,Osteoclast differentiation,126,0.444318862018209,1.76321654751053,0.00403225806451613,0.0206019871420222,0.0117659724999231,KG,mono-sp-vs-hc
hsa04911,Insulin secretion,55,0.482498642265916,1.68612412875246,0.00403225806451613,0.0206019871420222,0.0117659724999231,KG,mono-sp-vs-hc
hsa04713,Circadian entrainment,65,0.512924978887196,1.83420491463949,0.00404858299595142,0.0206019871420222,0.0117659724999231,KG,mono-sp-vs-hc
hsa04722,Neurotrophin signaling pathway,105,0.448647454102912,1.72693057530648,0.00409836065573771,0.0206019871420222,0.0117659724999231,KG,mono-sp-vs-hc
hsa05414,Dilated cardiomyopathy,64,0.432437679812751,1.53802956261133,0.00409836065573771,0.0206019871420222,0.0117659724999231,KG,mono-sp-vs-hc
hsa04668,TNF signaling pathway,102,0.447855289958498,1.70831628755042,0.00411522633744856,0.0206019871420222,0.0117659724999231,KG,mono-sp-vs-hc
hsa03430,Mismatch repair,23,-0.629529915045521,-1.76309338503506,0.00416666666666667,0.0206019871420222,0.0117659724999231,KG,mono-sp-vs-hc
hsa04666,Fc gamma R-mediated phagocytosis,84,0.47025473922131,1.7666781255124,0.00416666666666667,0.0206019871420222,0.0117659724999231,KG,mono-sp-vs-hc
hsa04918,Thyroid hormone synthesis,59,0.493601219028027,1.737865270923,0.00416666666666667,0.0206019871420222,0.0117659724999231,KG,mono-sp-vs-hc
hsa04972,Pancreatic secretion,58,0.519092387022961,1.81763550175741,0.00416666666666667,0.0206019871420222,0.0117659724999231,KG,mono-sp-vs-hc
hsa03008,Ribosome biogenesis in eukaryotes,70,-0.605716649284881,-2.23570522677906,0.00418410041841004,0.0206019871420222,0.0117659724999231,KG,mono-sp-vs-hc
hsa03420,Nucleotide excision repair,45,-0.526135144722854,-1.77210769611194,0.00418410041841004,0.0206019871420222,0.0117659724999231,KG,mono-sp-vs-hc
hsa05169,Epstein-Barr virus infection,194,0.386115043120853,1.62395838232301,0.00420168067226891,0.0206019871420222,0.0117659724999231,KG,mono-sp-vs-hc
hsa05416,Viral myocarditis,55,0.605807110202655,2.1071160536992,0.00420168067226891,0.0206019871420222,0.0117659724999231,KG,mono-sp-vs-hc
hsa04970,Salivary secretion,58,0.487581891618265,1.74338223639277,0.00421940928270042,0.0206019871420222,0.0117659724999231,KG,mono-sp-vs-hc
hsa03013,RNA transport,151,-0.412496783890112,-1.69246950989792,0.00423728813559322,0.0206019871420222,0.0117659724999231,KG,mono-sp-vs-hc
hsa05131,Shigellosis,62,0.584370901239763,2.08268062294509,0.00423728813559322,0.0206019871420222,0.0117659724999231,KG,mono-sp-vs-hc
hsa04145,Phagosome,136,0.447840448095877,1.80322935998087,0.00431034482758621,0.0206019871420222,0.0117659724999231,KG,mono-sp-vs-hc
hsa05168,Herpes simplex infection,166,0.347005491903842,1.42863978594919,0.00754716981132075,0.0305691056910569,0.0174582798459564,KG,mono-sp-vs-hc
hsa04064,NF-kappa B signaling pathway,83,0.413924738350867,1.53551193213028,0.00763358778625954,0.0305691056910569,0.0174582798459564,KG,mono-sp-vs-hc
hsa04142,Lysosome,119,0.405668231043165,1.60096745997992,0.00763358778625954,0.0305691056910569,0.0174582798459564,KG,mono-sp-vs-hc
hsa04260,Cardiac muscle contraction,52,0.492605925136583,1.69767373403519,0.00772200772200772,0.0305691056910569,0.0174582798459564,KG,mono-sp-vs-hc
hsa03030,DNA replication,36,-0.536936465864109,-1.73599710336016,0.00775193798449612,0.0305691056910569,0.0174582798459564,KG,mono-sp-vs-hc
hsa04750,Inflammatory mediator regulation of TRP channels,76,0.402883457827755,1.49826815735473,0.00775193798449612,0.0305691056910569,0.0174582798459564,KG,mono-sp-vs-hc
hsa03450,Non-homologous end-joining,12,-0.698162467982164,-1.72588493890503,0.0078740157480315,0.0305691056910569,0.0174582798459564,KG,mono-sp-vs-hc
hsa04920,Adipocytokine signaling pathway,63,0.480883166790808,1.69723767651594,0.00790513833992095,0.0305691056910569,0.0174582798459564,KG,mono-sp-vs-hc
hsa05133,Pertussis,63,0.493354390929346,1.78891552623383,0.00790513833992095,0.0305691056910569,0.0174582798459564,KG,mono-sp-vs-hc
hsa05140,Leishmaniasis,69,0.475917992081257,1.77160522248397,0.00793650793650794,0.0305691056910569,0.0174582798459564,KG,mono-sp-vs-hc
hsa04662,B cell receptor signaling pathway,69,0.444070323874202,1.5885040502815,0.00796812749003984,0.0305691056910569,0.0174582798459564,KG,mono-sp-vs-hc
hsa05032,Morphine addiction,57,0.477361538443576,1.67597488235573,0.00796812749003984,0.0305691056910569,0.0174582798459564,KG,mono-sp-vs-hc
hsa04724,Glutamatergic synapse,79,0.449351611333386,1.70866914138662,0.00803212851405622,0.0305691056910569,0.0174582798459564,KG,mono-sp-vs-hc
hsa05031,Amphetamine addiction,45,0.494196186472928,1.67212058697929,0.00803212851405622,0.0305691056910569,0.0174582798459564,KG,mono-sp-vs-hc
hsa04912,GnRH signaling pathway,73,0.436878541857114,1.62565606617997,0.00806451612903226,0.0305691056910569,0.0174582798459564,KG,mono-sp-vs-hc
hsa05132,Salmonella infection,74,0.412661150150003,1.52724656255372,0.00813008130081301,0.0305691056910569,0.0174582798459564,KG,mono-sp-vs-hc
hsa04146,Peroxisome,75,-0.419691650259149,-1.56121368046285,0.00829875518672199,0.0307927495086263,0.017586004758566,KG,mono-sp-vs-hc
hsa05215,Prostate cancer,79,0.423055348567186,1.54590065550622,0.010989010989011,0.0400227079193869,0.0228573135933788,KG,mono-sp-vs-hc
hsa04520,Adherens junction,65,0.437021043507657,1.5528014412691,0.011070110701107,0.0400227079193869,0.0228573135933788,KG,mono-sp-vs-hc
hsa04261,Adrenergic signaling in cardiomyocytes,112,0.384059146531919,1.506405787662,0.0114068441064639,0.0407181017471242,0.0232544590045166,KG,mono-sp-vs-hc
hsa05146,Amoebiasis,75,0.402956347767094,1.47491383552114,0.0116731517509728,0.041147859922179,0.023499897603932,KG,mono-sp-vs-hc
hsa04971,Gastric acid secretion,57,0.425548864778762,1.48538682998903,0.0119521912350598,0.0416011014948859,0.023758747774235,KG,mono-sp-vs-hc
hsa04978,Mineral absorption,40,0.476639774448153,1.56371405247421,0.0120967741935484,0.0416011014948859,0.023758747774235,KG,mono-sp-vs-hc
hsa00280,Valine, leucine and isoleucine degradation,43,-0.497595739850004,-1.63816687208663,0.0122448979591837,0.0416031472830096,0.0237599161414724,KG,mono-sp-vs-hc
hsa05030,Cocaine addiction,32,0.534400443472015,1.67444497599307,0.0125523012552301,0.0421398684997011,0.0240664422562683,KG,mono-sp-vs-hc
hsa04610,Complement and coagulation cascades,58,0.461797830496135,1.60385858676667,0.0127118644067797,0.0421734795613161,0.024085637823372,KG,mono-sp-vs-hc
hsa00480,Glutathione metabolism,44,0.500375788181637,1.60963214803227,0.0145985401459854,0.047869631641487,0.0273387593921146,KG,mono-sp-vs-hc
hsa04933,AGE-RAGE signaling pathway in diabetic complications,85,0.392293866958866,1.4824467825669,0.0153846153846154,0.0491053937573462,0.0280445137919894,KG,mono-sp-vs-hc
hsa04922,Glucagon signaling pathway,81,0.403661173456664,1.51297461204543,0.0155038759689922,0.0491053937573462,0.0280445137919894,KG,mono-sp-vs-hc
hsa04630,Jak-STAT signaling pathway,116,0.387342684598536,1.49157573043011,0.015625,0.0491053937573462,0.0280445137919894,KG,mono-sp-vs-hc
hsa04141,Protein processing in endoplasmic reticulum,158,0.335958573111048,1.37490385317215,0.0158102766798419,0.0491053937573462,0.0280445137919894,KG,mono-sp-vs-hc
hsa05166,HTLV-I infection,231,0.31070193562759,1.33825391723941,0.0159362549800797,0.0491053937573462,0.0280445137919894,KG,mono-sp-vs-hc
hsa04924,Renin secretion,42,0.470900460963303,1.5872987739398,0.0161290322580645,0.0491053937573462,0.0280445137919894,KG,mono-sp-vs-hc
hsa04961,Endocrine and other factor-regulated calcium reabsorption,41,0.445555662148513,1.48017274681811,0.0161943319838057,0.0491053937573462,0.0280445137919894,KG,mono-sp-vs-hc
hsa04390,Hippo signaling pathway,124,0.378893908954594,1.50111469471343,0.0176678445229682,0.0530035335689046,0.0302707750505502,KG,mono-sp-vs-hc
hsa04910,Insulin signaling pathway,119,0.351655167400454,1.37844991219604,0.0183150183150183,0.0543666859456333,0.0310492831268455,KG,mono-sp-vs-hc
hsa05110,Vibrio cholerae infection,44,0.474216893285409,1.57027082962052,0.0187265917602996,0.0546511627906977,0.0312117503059976,KG,mono-sp-vs-hc
hsa05221,Acute myeloid leukemia,56,0.427298542316892,1.48828449567827,0.0190839694656489,0.0546511627906977,0.0312117503059976,KG,mono-sp-vs-hc
hsa05200,Pathways in cancer,318,0.289528819819132,1.28280885665413,0.0191570881226054,0.0546511627906977,0.0312117503059976,KG,mono-sp-vs-hc
hsa04071,Sphingolipid signaling pathway,112,0.359877841534979,1.45313401443058,0.0193798449612403,0.0546511627906977,0.0312117503059976,KG,mono-sp-vs-hc
hsa04660,T cell receptor signaling pathway,95,0.39118050232453,1.4580309313427,0.0193798449612403,0.0546511627906977,0.0312117503059976,KG,mono-sp-vs-hc
hsa00970,Aminoacyl-tRNA biosynthesis,43,-0.443951726118662,-1.46201597993819,0.0196078431372549,0.0547466511357018,0.0312662845231892,KG,mono-sp-vs-hc
hsa05410,Hypertrophic cardiomyopathy (HCM),61,0.41549244096472,1.46244653765771,0.0202429149797571,0.0559657061205049,0.0319624973364586,KG,mono-sp-vs-hc
hsa04744,Phototransduction,17,0.573162239024822,1.5950752635189,0.0209205020920502,0.0572774911646423,0.0327116690861899,KG,mono-sp-vs-hc
hsa05150,Staphylococcus aureus infection,48,0.419864550417088,1.42519789555372,0.0221238938053097,0.0599044078597982,0.0342119238616989,KG,mono-sp-vs-hc
hsa04270,Vascular smooth muscle contraction,83,0.372963903698711,1.44126094927288,0.0223048327137546,0.0599044078597982,0.0342119238616989,KG,mono-sp-vs-hc
hsa04068,FoxO signaling pathway,123,0.362047974740093,1.43880903143371,0.0229007633587786,0.0605865291653239,0.0346014892209576,KG,mono-sp-vs-hc
hsa03410,Base excision repair,33,-0.514700597165304,-1.5853959552727,0.0229885057471264,0.0605865291653239,0.0346014892209576,KG,mono-sp-vs-hc
hsa04964,Proximal tubule bicarbonate reclamation,16,0.61568033640014,1.64896255818746,0.0256410256410256,0.066951566951567,0.0382366171839856,KG,mono-sp-vs-hc
hsa04612,Antigen processing and presentation,65,0.403603202357482,1.47635338358452,0.0274509803921569,0.0706513958482462,0.0403496213690992,KG,mono-sp-vs-hc
hsa04925,Aldosterone synthesis and secretion,59,0.424622610915003,1.49873259077783,0.0275590551181102,0.0706513958482462,0.0403496213690992,KG,mono-sp-vs-hc
hsa05144,Malaria,37,0.503494353818181,1.61572081132875,0.0278884462151394,0.0708517282222461,0.0404640329152806,KG,mono-sp-vs-hc
hsa00600,Sphingolipid metabolism,39,0.460713420673996,1.51657244295685,0.0282258064516129,0.0710685483870968,0.0405878607809847,KG,mono-sp-vs-hc
hsa00071,Fatty acid degradation,33,-0.474553150579551,-1.50615111123416,0.0289256198347107,0.0721860601184817,0.0412260813666581,KG,mono-sp-vs-hc
hsa04060,Cytokine-cytokine receptor interaction,186,0.312058024516318,1.3028157813957,0.029520295202952,0.0724270776004403,0.0413637285288069,KG,mono-sp-vs-hc
hsa05212,Pancreatic cancer,65,0.40987679742232,1.43571517907772,0.029535864978903,0.0724270776004403,0.0413637285288069,KG,mono-sp-vs-hc
hsa04512,ECM-receptor interaction,51,0.429868014071842,1.45520239694325,0.0306513409961686,0.0745144669044788,0.0425558545591088,KG,mono-sp-vs-hc
hsa00640,Propanoate metabolism,32,-0.464878824379869,-1.45472176083116,0.0313725490196078,0.0755677631138206,0.0431574011064373,KG,mono-sp-vs-hc
hsa04120,Ubiquitin mediated proteolysis,130,0.330041951644618,1.32028499910402,0.0316205533596838,0.0755677631138206,0.0431574011064373,KG,mono-sp-vs-hc
DOID:0050615,respiratory system cancer,471,0.325095615347768,1.50121740940803,0.00347222222222222,0.0281811085089774,0.0188997082871112,DO,mono-sp-vs-hc
DOID:18,urinary system disease,345,0.356250875281664,1.59850282036755,0.00352112676056338,0.0281811085089774,0.0188997082871112,DO,mono-sp-vs-hc
DOID:5419,schizophrenia,468,0.353377568122791,1.61334091162374,0.00353356890459364,0.0281811085089774,0.0188997082871112,DO,mono-sp-vs-hc
DOID:2468,psychotic disorder,471,0.353481131737764,1.61435720251958,0.00355871886120996,0.0281811085089774,0.0188997082871112,DO,mono-sp-vs-hc
DOID:3312,bipolar disorder,110,0.410923988473238,1.56874693850249,0.00355871886120996,0.0281811085089774,0.0188997082871112,DO,mono-sp-vs-hc
DOID:9351,diabetes mellitus,476,0.329636782589022,1.5217846383386,0.003584229390681,0.0281811085089774,0.0188997082871112,DO,mono-sp-vs-hc
DOID:0060084,cell type benign neoplasm,342,0.3049452851309,1.38344919874668,0.0036101083032491,0.0281811085089774,0.0188997082871112,DO,mono-sp-vs-hc
DOID:3905,lung carcinoma,398,0.332087769475832,1.50529654649984,0.0036101083032491,0.0281811085089774,0.0188997082871112,DO,mono-sp-vs-hc
DOID:557,kidney disease,335,0.360424846444733,1.60900192828824,0.0036101083032491,0.0281811085089774,0.0188997082871112,DO,mono-sp-vs-hc
DOID:10652,Alzheimer's disease,335,0.389641063426011,1.72609490807384,0.0036231884057971,0.0281811085089774,0.0188997082871112,DO,mono-sp-vs-hc
DOID:1612,breast cancer,419,0.339586932990569,1.53126001806365,0.0036231884057971,0.0281811085089774,0.0188997082871112,DO,mono-sp-vs-hc
DOID:403,mouth disease,131,0.355536875156508,1.42321366141778,0.0036231884057971,0.0281811085089774,0.0188997082871112,DO,mono-sp-vs-hc
DOID:5093,thoracic cancer,419,0.339586932990569,1.53126001806365,0.0036231884057971,0.0281811085089774,0.0188997082871112,DO,mono-sp-vs-hc
DOID:1037,lymphoblastic leukemia,347,0.333822761196508,1.49321035480682,0.00363636363636364,0.0281811085089774,0.0188997082871112,DO,mono-sp-vs-hc
DOID:1324,lung cancer,463,0.325151768867248,1.49090228043488,0.00363636363636364,0.0281811085089774,0.0188997082871112,DO,mono-sp-vs-hc
DOID:114,heart disease,357,0.338613162629664,1.51255205330679,0.00364963503649635,0.0281811085089774,0.0188997082871112,DO,mono-sp-vs-hc
DOID:4989,pancreatitis,84,0.446413050927741,1.67949084765424,0.00364963503649635,0.0281811085089774,0.0188997082871112,DO,mono-sp-vs-hc
DOID:0060100,musculoskeletal system cancer,354,0.370617803075821,1.66161650335501,0.00366300366300366,0.0281811085089774,0.0188997082871112,DO,mono-sp-vs-hc
DOID:1936,atherosclerosis,263,0.396332293935017,1.71460099593391,0.00367647058823529,0.0281811085089774,0.0188997082871112,DO,mono-sp-vs-hc
DOID:1307,dementia,112,0.426651613154548,1.65627903132691,0.003690036900369,0.0281811085089774,0.0188997082871112,DO,mono-sp-vs-hc
DOID:3393,coronary artery disease,245,0.351618674941392,1.52349836209528,0.003690036900369,0.0281811085089774,0.0188997082871112,DO,mono-sp-vs-hc
DOID:5844,myocardial infarction,197,0.367133011642127,1.5554606062675,0.003690036900369,0.0281811085089774,0.0188997082871112,DO,mono-sp-vs-hc
DOID:680,tauopathy,338,0.384058754399631,1.69868667637249,0.003690036900369,0.0281811085089774,0.0188997082871112,DO,mono-sp-vs-hc
DOID:2349,arteriosclerosis,272,0.390144044487353,1.68822844386229,0.0037037037037037,0.0281811085089774,0.0188997082871112,DO,mono-sp-vs-hc
DOID:3083,chronic obstructive pulmonary disease,166,0.374010112888653,1.54722257553328,0.0037037037037037,0.0281811085089774,0.0188997082871112,DO,mono-sp-vs-hc
DOID:374,nutrition disease,238,0.380901766026658,1.64450758617618,0.0037037037037037,0.0281811085089774,0.0188997082871112,DO,mono-sp-vs-hc
DOID:0050161,lower respiratory tract disease,369,0.332197102057243,1.49789385732198,0.00371747211895911,0.0281811085089774,0.0188997082871112,DO,mono-sp-vs-hc
DOID:10763,hypertension,405,0.368711012647228,1.6578880565065,0.00371747211895911,0.0281811085089774,0.0188997082871112,DO,mono-sp-vs-hc
DOID:2237,hepatitis,358,0.322072192435677,1.43348469710866,0.00371747211895911,0.0281811085089774,0.0188997082871112,DO,mono-sp-vs-hc
DOID:326,ischemia,163,0.421825030360826,1.74731461351217,0.00371747211895911,0.0281811085089774,0.0188997082871112,DO,mono-sp-vs-hc
DOID:3459,breast carcinoma,312,0.350371233801042,1.53265940903773,0.00371747211895911,0.0281811085089774,0.0188997082871112,DO,mono-sp-vs-hc
DOID:0050338,primary bacterial infectious disease,193,0.353201727790013,1.47219629785821,0.00373134328358209,0.0281811085089774,0.0188997082871112,DO,mono-sp-vs-hc
DOID:0060072,benign neoplasm,409,0.32025223614859,1.45825214320433,0.00373134328358209,0.0281811085089774,0.0188997082871112,DO,mono-sp-vs-hc
DOID:1883,hepatitis C,198,0.342111805314886,1.43603222015827,0.00373134328358209,0.0281811085089774,0.0188997082871112,DO,mono-sp-vs-hc
DOID:2348,arteriosclerotic cardiovascular disease,264,0.391709407421854,1.69019386694772,0.00373134328358209,0.0281811085089774,0.0188997082871112,DO,mono-sp-vs-hc
DOID:26,pancreas disease,119,0.409004993084164,1.63731279979909,0.00373134328358209,0.0281811085089774,0.0188997082871112,DO,mono-sp-vs-hc
DOID:2621,autonomic nervous system neoplasm,275,0.387500816491061,1.69453462247205,0.00373134328358209,0.0281811085089774,0.0188997082871112,DO,mono-sp-vs-hc
DOID:769,neuroblastoma,275,0.387500816491061,1.69453462247205,0.00373134328358209,0.0281811085089774,0.0188997082871112,DO,mono-sp-vs-hc
DOID:10283,prostate cancer,332,0.336986999269301,1.52258221479141,0.00374531835205993,0.0281811085089774,0.0188997082871112,DO,mono-sp-vs-hc
DOID:201,connective tissue cancer,300,0.379133980675156,1.65847055999856,0.00374531835205993,0.0281811085089774,0.0188997082871112,DO,mono-sp-vs-hc
DOID:9970,obesity,222,0.396227655843181,1.69591951363104,0.00374531835205993,0.0281811085089774,0.0188997082871112,DO,mono-sp-vs-hc
DOID:1168,familial hyperlipidemia,59,0.482112615659535,1.71236572737638,0.0037593984962406,0.0281811085089774,0.0188997082871112,DO,mono-sp-vs-hc
DOID:1800,neuroendocrine carcinoma,14,0.82938327414744,2.11294425045078,0.0037593984962406,0.0281811085089774,0.0188997082871112,DO,mono-sp-vs-hc
DOID:28,endocrine system disease,278,0.323052062126747,1.42203847615847,0.0037593984962406,0.0281811085089774,0.0188997082871112,DO,mono-sp-vs-hc
DOID:526,Human immunodeficiency virus infectious disease,144,0.381971640685861,1.53491277334435,0.0037593984962406,0.0281811085089774,0.0188997082871112,DO,mono-sp-vs-hc
DOID:583,hemolytic anemia,46,0.528142335348783,1.76759499095568,0.0037593984962406,0.0281811085089774,0.0188997082871112,DO,mono-sp-vs-hc
DOID:720,normocytic anemia,46,0.528142335348783,1.76759499095568,0.0037593984962406,0.0281811085089774,0.0188997082871112,DO,mono-sp-vs-hc
DOID:850,lung disease,361,0.321945727562713,1.44636158185555,0.0037593984962406,0.0281811085089774,0.0188997082871112,DO,mono-sp-vs-hc
DOID:1602,lymphadenitis,46,0.526734979496765,1.78386865502321,0.00377358490566038,0.0281811085089774,0.0188997082871112,DO,mono-sp-vs-hc
DOID:9538,multiple myeloma,217,0.377904328833168,1.61654766387202,0.00377358490566038,0.0281811085089774,0.0188997082871112,DO,mono-sp-vs-hc
DOID:9942,lymph node disease,46,0.526734979496765,1.78386865502321,0.00377358490566038,0.0281811085089774,0.0188997082871112,DO,mono-sp-vs-hc
DOID:1579,respiratory system disease,410,0.321448219933486,1.45317292970858,0.00378787878787879,0.0281811085089774,0.0188997082871112,DO,mono-sp-vs-hc
DOID:0070004,myeloma,262,0.379733143342203,1.65508676519441,0.00380228136882129,0.0281811085089774,0.0188997082871112,DO,mono-sp-vs-hc
DOID:7148,rheumatoid arthritis,433,0.360880453262382,1.62952064333855,0.00380228136882129,0.0281811085089774,0.0188997082871112,DO,mono-sp-vs-hc
DOID:16,integumentary system disease,286,0.305720853749907,1.34901626222758,0.00381679389312977,0.0281811085089774,0.0188997082871112,DO,mono-sp-vs-hc
DOID:1826,epilepsy syndrome,141,0.405377716168475,1.61334159804854,0.00381679389312977,0.0281811085089774,0.0188997082871112,DO,mono-sp-vs-hc
DOID:2018,hyperinsulinism,37,0.533929619587428,1.77544065349868,0.00381679389312977,0.0281811085089774,0.0188997082871112,DO,mono-sp-vs-hc
DOID:2320,obstructive lung disease,223,0.356880737928026,1.53372519296703,0.00381679389312977,0.0281811085089774,0.0188997082871112,DO,mono-sp-vs-hc
DOID:3856,male reproductive organ cancer,340,0.33521245404174,1.5165266228151,0.00381679389312977,0.0281811085089774,0.0188997082871112,DO,mono-sp-vs-hc
DOID:654,overnutrition,228,0.396756052026489,1.70320551660578,0.00381679389312977,0.0281811085089774,0.0188997082871112,DO,mono-sp-vs-hc
DOID:657,adenoma,236,0.323654461663701,1.40461409505979,0.00381679389312977,0.0281811085089774,0.0188997082871112,DO,mono-sp-vs-hc
DOID:10591,pre-eclampsia,194,0.381956821663553,1.60404216952197,0.00383141762452107,0.0281811085089774,0.0188997082871112,DO,mono-sp-vs-hc
DOID:3093,nervous system cancer,419,0.360959663562778,1.64043081718728,0.00383141762452107,0.0281811085089774,0.0188997082871112,DO,mono-sp-vs-hc
DOID:7693,abdominal aortic aneurysm,36,0.632509727414543,2.05139467605275,0.00383141762452107,0.0281811085089774,0.0188997082871112,DO,mono-sp-vs-hc
DOID:1247,blood coagulation disease,143,0.4314740101969,1.7444478900909,0.00384615384615385,0.0281811085089774,0.0188997082871112,DO,mono-sp-vs-hc
DOID:13378,Kawasaki disease,42,0.507826757130689,1.67955211856509,0.00384615384615385,0.0281811085089774,0.0188997082871112,DO,mono-sp-vs-hc
DOID:184,bone cancer,196,0.350558978972565,1.46267171727522,0.00384615384615385,0.0281811085089774,0.0188997082871112,DO,mono-sp-vs-hc
DOID:3908,non-small cell lung carcinoma,334,0.340321846600404,1.52223285579131,0.00384615384615385,0.0281811085089774,0.0188997082871112,DO,mono-sp-vs-hc
DOID:784,chronic kidney failure,49,0.526004837771395,1.80314738413339,0.00384615384615385,0.0281811085089774,0.0188997082871112,DO,mono-sp-vs-hc
DOID:104,bacterial infectious disease,221,0.363344752984839,1.53515030582829,0.00386100386100386,0.0281811085089774,0.0188997082871112,DO,mono-sp-vs-hc
DOID:3146,lipid metabolism disorder,67,0.475668345634396,1.71762678905938,0.00386100386100386,0.0281811085089774,0.0188997082871112,DO,mono-sp-vs-hc
DOID:3627,aortic aneurysm,46,0.660858958948196,2.23842092302833,0.00386100386100386,0.0281811085089774,0.0188997082871112,DO,mono-sp-vs-hc
DOID:520,aortic disease,46,0.660858958948196,2.23842092302833,0.00386100386100386,0.0281811085089774,0.0188997082871112,DO,mono-sp-vs-hc
DOID:8398,osteoarthritis,138,0.383843761340262,1.56304206380959,0.00386100386100386,0.0281811085089774,0.0188997082871112,DO,mono-sp-vs-hc
DOID:263,kidney cancer,330,0.309864819950142,1.38775903060192,0.00387596899224806,0.0281811085089774,0.0188997082871112,DO,mono-sp-vs-hc
DOID:3371,chondrosarcoma,52,0.464886403855078,1.60746060245408,0.00387596899224806,0.0281811085089774,0.0188997082871112,DO,mono-sp-vs-hc
DOID:4960,bone marrow cancer,267,0.375947050619854,1.63413965888925,0.00387596899224806,0.0281811085089774,0.0188997082871112,DO,mono-sp-vs-hc
DOID:0060180,colitis,46,0.589052887968303,1.94718898336645,0.00389105058365759,0.0281811085089774,0.0188997082871112,DO,mono-sp-vs-hc
DOID:1192,peripheral nervous system neoplasm,289,0.377830016368379,1.65046950087841,0.00389105058365759,0.0281811085089774,0.0188997082871112,DO,mono-sp-vs-hc
DOID:13810,familial hypercholesterolemia,14,0.740602118770567,1.82136780754815,0.00389105058365759,0.0281811085089774,0.0188997082871112,DO,mono-sp-vs-hc
DOID:6000,congestive heart failure,149,0.440141088465226,1.77090807882967,0.00389105058365759,0.0281811085089774,0.0188997082871112,DO,mono-sp-vs-hc
DOID:6713,cerebrovascular disease,81,0.539120729314464,2.02712893271596,0.00389105058365759,0.0281811085089774,0.0188997082871112,DO,mono-sp-vs-hc
DOID:8577,ulcerative colitis,46,0.589052887968303,1.94718898336645,0.00389105058365759,0.0281811085089774,0.0188997082871112,DO,mono-sp-vs-hc
DOID:3407,carotid artery disease,12,0.76764900869591,1.87779501618825,0.00390625,0.0281811085089774,0.0188997082871112,DO,mono-sp-vs-hc
DOID:3996,urinary system cancer,378,0.320428011245494,1.45196105735439,0.00390625,0.0281811085089774,0.0188997082871112,DO,mono-sp-vs-hc
DOID:2214,inherited blood coagulation disease,14,0.73720973001397,1.8804518894449,0.00392156862745098,0.0281811085089774,0.0188997082871112,DO,mono-sp-vs-hc
DOID:37,skin disease,250,0.3221560128304,1.40763324960573,0.00392156862745098,0.0281811085089774,0.0188997082871112,DO,mono-sp-vs-hc
DOID:783,end stage renal failure,27,0.589287988939905,1.79868517713525,0.00392156862745098,0.0281811085089774,0.0188997082871112,DO,mono-sp-vs-hc
DOID:9455,lipid storage disease,95,0.437305027922847,1.66053134355299,0.00392156862745098,0.0281811085089774,0.0188997082871112,DO,mono-sp-vs-hc
DOID:0050589,inflammatory bowel disease,61,0.57124240006546,1.99966650145643,0.00395256916996047,0.0281811085089774,0.0188997082871112,DO,mono-sp-vs-hc
DOID:9352,type 2 diabetes mellitus,154,0.417520495132969,1.72739913958092,0.00395256916996047,0.0281811085089774,0.0188997082871112,DO,mono-sp-vs-hc
DOID:417,hypersensitivity reaction type II disease,458,0.34334322900831,1.55648051274277,0.00396825396825397,0.0281811085089774,0.0188997082871112,DO,mono-sp-vs-hc
DOID:811,lipodystrophy,28,0.657604036209149,2.02439533125008,0.00396825396825397,0.0281811085089774,0.0188997082871112,DO,mono-sp-vs-hc
DOID:936,brain disease,314,0.371158336519056,1.63541407906867,0.00396825396825397,0.0281811085089774,0.0188997082871112,DO,mono-sp-vs-hc
DOID:0060122,integumentary system cancer,76,0.45148279505272,1.67917391891661,0.00398406374501992,0.0281811085089774,0.0188997082871112,DO,mono-sp-vs-hc
DOID:3211,lysosomal storage disease,115,0.434751194010735,1.6909998519751,0.00398406374501992,0.0281811085089774,0.0188997082871112,DO,mono-sp-vs-hc
DOID:4159,skin cancer,76,0.45148279505272,1.67917391891661,0.00398406374501992,0.0281811085089774,0.0188997082871112,DO,mono-sp-vs-hc
DOID:5295,intestinal disease,98,0.506274845662256,1.92640655242615,0.00398406374501992,0.0281811085089774,0.0188997082871112,DO,mono-sp-vs-hc
DOID:1074,kidney failure,111,0.499328362781794,1.93056578750527,0.00401606425702811,0.0281811085089774,0.0188997082871112,DO,mono-sp-vs-hc
DOID:120,female reproductive organ cancer,358,0.331030190085812,1.49283322960771,0.00401606425702811,0.0281811085089774,0.0188997082871112,DO,mono-sp-vs-hc
DOID:2355,anemia,197,0.330746867248907,1.3761675519539,0.00401606425702811,0.0281811085089774,0.0188997082871112,DO,mono-sp-vs-hc
DOID:0060089,endocrine organ benign neoplasm,69,0.431426328351662,1.59764027744602,0.00403225806451613,0.0281811085089774,0.0188997082871112,DO,mono-sp-vs-hc
DOID:10534,stomach cancer,203,0.362746324088094,1.55236452120986,0.0040650406504065,0.0281811085089774,0.0188997082871112,DO,mono-sp-vs-hc
DOID:1588,thrombocytopenia,57,0.459830520043569,1.60438066848408,0.0040650406504065,0.0281811085089774,0.0188997082871112,DO,mono-sp-vs-hc
DOID:12206,dengue hemorrhagic fever,13,0.709231325808747,1.76441175476019,0.00409836065573771,0.0281811085089774,0.0188997082871112,DO,mono-sp-vs-hc
DOID:0060085,organ system benign neoplasm,186,0.389539136204371,1.62986961573151,0.00418410041841004,0.0282329018887107,0.0189344436052004,DO,mono-sp-vs-hc
DOID:3451,skin carcinoma,46,0.594081776523481,2.035734007063,0.00418410041841004,0.0282329018887107,0.0189344436052004,DO,mono-sp-vs-hc
DOID:3829,pituitary adenoma,44,0.511867502239051,1.67962845998897,0.00423728813559322,0.0283270558694288,0.0189975881322893,DO,mono-sp-vs-hc
DOID:3454,brain infarction,43,0.555526076089727,1.8236497890534,0.00436681222707424,0.0289251231921798,0.0193986829981086,DO,mono-sp-vs-hc
DOID:0080005,bone remodeling disease,98,0.436194570925301,1.67643662487126,0.00709219858156028,0.038974358974359,0.0261382200440372,DO,mono-sp-vs-hc
DOID:3324,mood disorder,134,0.393955184057627,1.54190990815572,0.00709219858156028,0.038974358974359,0.0261382200440372,DO,mono-sp-vs-hc
DOID:1712,aortic valve stenosis,15,0.653273818074823,1.65996559402324,0.00735294117647059,0.038974358974359,0.0261382200440372,DO,mono-sp-vs-hc
DOID:1532,pleural disease,18,0.606908534650676,1.65801048320057,0.00738007380073801,0.038974358974359,0.0261382200440372,DO,mono-sp-vs-hc
DOID:381,arthropathy,70,0.414126778007724,1.48816890270778,0.00740740740740741,0.038974358974359,0.0261382200440372,DO,mono-sp-vs-hc
DOID:399,tuberculosis,123,0.36154918484139,1.42955156083861,0.00746268656716418,0.038974358974359,0.0261382200440372,DO,mono-sp-vs-hc
DOID:2377,multiple sclerosis,134,0.37135281073946,1.48047456250548,0.00749063670411985,0.038974358974359,0.0261382200440372,DO,mono-sp-vs-hc
DOID:409,liver disease,495,0.290808342308561,1.32876760959356,0.00749063670411985,0.038974358974359,0.0261382200440372,DO,mono-sp-vs-hc
DOID:3213,demyelinating disease,137,0.383906152281367,1.53595377827159,0.0075187969924812,0.038974358974359,0.0261382200440372,DO,mono-sp-vs-hc
DOID:62,aortic valve disease,19,0.629344224238481,1.6859051946399,0.0075187969924812,0.038974358974359,0.0261382200440372,DO,mono-sp-vs-hc
DOID:3347,osteosarcoma,177,0.334790600159826,1.38036524102028,0.00757575757575758,0.038974358974359,0.0261382200440372,DO,mono-sp-vs-hc
DOID:576,proteinuria,50,0.45955951558546,1.56439818745618,0.00757575757575758,0.038974358974359,0.0261382200440372,DO,mono-sp-vs-hc
DOID:12365,malaria,86,0.433470236516137,1.60221977089948,0.00760456273764259,0.038974358974359,0.0261382200440372,DO,mono-sp-vs-hc
DOID:10747,lymphoid leukemia,60,0.462515697001398,1.63620486762384,0.00763358778625954,0.038974358974359,0.0261382200440372,DO,mono-sp-vs-hc
DOID:10608,celiac disease,71,0.443370180836642,1.62550864011574,0.00766283524904215,0.038974358974359,0.0261382200440372,DO,mono-sp-vs-hc
DOID:11714,gestational diabetes,43,0.530161541533229,1.73864863812354,0.00766283524904215,0.038974358974359,0.0261382200440372,DO,mono-sp-vs-hc
DOID:13241,Behcet's disease,69,0.47107476546577,1.67410111645364,0.00766283524904215,0.038974358974359,0.0261382200440372,DO,mono-sp-vs-hc
DOID:2394,ovarian cancer,253,0.33415223333978,1.45824290549028,0.00766283524904215,0.038974358974359,0.0261382200440372,DO,mono-sp-vs-hc
DOID:4451,renal carcinoma,291,0.308233979234243,1.37824950980662,0.00769230769230769,0.038974358974359,0.0261382200440372,DO,mono-sp-vs-hc
DOID:1116,pertussis,30,0.565084298479484,1.76758002780667,0.00772200772200772,0.038974358974359,0.0261382200440372,DO,mono-sp-vs-hc
DOID:1428,endocrine pancreas disease,42,0.502874614953178,1.71528351429448,0.00772200772200772,0.038974358974359,0.0261382200440372,DO,mono-sp-vs-hc
DOID:74,hematopoietic system disease,377,0.323048113989444,1.44786341208724,0.00772200772200772,0.038974358974359,0.0261382200440372,DO,mono-sp-vs-hc
DOID:865,vasculitis,99,0.429630624571415,1.63921826846016,0.00772200772200772,0.038974358974359,0.0261382200440372,DO,mono-sp-vs-hc
DOID:9452,fatty liver disease,68,0.479976907868057,1.71728526960962,0.00772200772200772,0.038974358974359,0.0261382200440372,DO,mono-sp-vs-hc
DOID:200,giant cell tumor,15,0.673895680768085,1.71985280770936,0.00778210116731518,0.038974358974359,0.0261382200440372,DO,mono-sp-vs-hc
DOID:8552,chronic myeloid leukemia,23,0.605804705728099,1.7764489566517,0.00778210116731518,0.038974358974359,0.0261382200440372,DO,mono-sp-vs-hc
DOID:2921,glomerulonephritis,57,0.455256734045342,1.59047243749221,0.0078740157480315,0.038974358974359,0.0261382200440372,DO,mono-sp-vs-hc
DOID:3070,malignant glioma,162,0.325889080460327,1.35317646518335,0.0078740157480315,0.038974358974359,0.0261382200440372,DO,mono-sp-vs-hc
DOID:0050339,commensal bacterial infectious disease,34,0.548008187016351,1.72927176445102,0.00790513833992095,0.038974358974359,0.0261382200440372,DO,mono-sp-vs-hc
DOID:3151,skin squamous cell carcinoma,18,0.656516159022878,1.84101885357277,0.00793650793650794,0.038974358974359,0.0261382200440372,DO,mono-sp-vs-hc
DOID:8778,Crohn's disease,34,0.554044604322559,1.72627524928057,0.00793650793650794,0.038974358974359,0.0261382200440372,DO,mono-sp-vs-hc
DOID:10159,osteonecrosis,22,0.590174569914997,1.68491406032433,0.00796812749003984,0.038974358974359,0.0261382200440372,DO,mono-sp-vs-hc
DOID:1115,sarcoma,153,0.368528304010753,1.49759858525143,0.00796812749003984,0.038974358974359,0.0261382200440372,DO,mono-sp-vs-hc
DOID:3498,pancreatic ductal adenocarcinoma,81,0.469084112221796,1.77244667871308,0.00796812749003984,0.038974358974359,0.0261382200440372,DO,mono-sp-vs-hc
DOID:0080008,ischemic bone disease,30,0.552650068201171,1.69143072145206,0.008,0.038974358974359,0.0261382200440372,DO,mono-sp-vs-hc
DOID:2213,hemorrhagic disease,126,0.393764833226849,1.54700123622031,0.008,0.038974358974359,0.0261382200440372,DO,mono-sp-vs-hc
DOID:13207,proliferative diabetic retinopathy,23,0.564594473233773,1.60757148397847,0.00803212851405622,0.038974358974359,0.0261382200440372,DO,mono-sp-vs-hc
DOID:2513,basal cell carcinoma,20,0.626697848509446,1.79327491862938,0.00806451612903226,0.038974358974359,0.0261382200440372,DO,mono-sp-vs-hc
DOID:4195,hyperglycemia,106,0.422322260531704,1.63686078640206,0.00806451612903226,0.038974358974359,0.0261382200440372,DO,mono-sp-vs-hc
DOID:170,endocrine gland cancer,392,0.318566432480988,1.45096641179639,0.00809716599190283,0.038974358974359,0.0261382200440372,DO,mono-sp-vs-hc
DOID:1793,pancreatic cancer,245,0.341531768079879,1.47489394424978,0.00809716599190283,0.038974358974359,0.0261382200440372,DO,mono-sp-vs-hc
DOID:4676,uremia,14,0.728819207101262,1.83555316990607,0.00826446280991736,0.0395161731705982,0.0265015886550156,DO,mono-sp-vs-hc
DOID:12205,dengue disease,15,0.648812199155282,1.68379212186151,0.00847457627118644,0.0402542372881356,0.0269965726090427,DO,mono-sp-vs-hc
DOID:2218,blood platelet disease,80,0.458426747509701,1.69366112187978,0.00862068965517241,0.0406806400721208,0.0272825403603668,DO,mono-sp-vs-hc
DOID:1596,mental depression,29,0.529973110658896,1.58501860089256,0.0108695652173913,0.0507616592453715,0.0340433929915015,DO,mono-sp-vs-hc
DOID:0060031,autoimmune disease of gastrointestinal tract,86,0.42215201978913,1.57727632218406,0.0111111111111111,0.0507616592453715,0.0340433929915015,DO,mono-sp-vs-hc
DOID:2916,hypersensitivity reaction type IV disease,68,0.436170940947348,1.57244189376094,0.0111524163568773,0.0507616592453715,0.0340433929915015,DO,mono-sp-vs-hc
DOID:11335,sarcoidosis,64,0.44148979431817,1.57695048583147,0.0111940298507463,0.0507616592453715,0.0340433929915015,DO,mono-sp-vs-hc
DOID:10825,essential hypertension,79,0.434470845294292,1.62147868295642,0.0113207547169811,0.0507616592453715,0.0340433929915015,DO,mono-sp-vs-hc
DOID:10952,nephritis,116,0.347832587002897,1.38078123972979,0.0113207547169811,0.0507616592453715,0.0340433929915015,DO,mono-sp-vs-hc
DOID:1107,esophageal carcinoma,94,0.39469927190604,1.53277051121739,0.0114942528735632,0.0507616592453715,0.0340433929915015,DO,mono-sp-vs-hc
DOID:10603,glucose intolerance,37,0.530093432063074,1.67496280452701,0.0115384615384615,0.0507616592453715,0.0340433929915015,DO,mono-sp-vs-hc
DOID:12554,hemolytic-uremic syndrome,17,0.649214142338966,1.70261521124927,0.0116279069767442,0.0507616592453715,0.0340433929915015,DO,mono-sp-vs-hc
DOID:13580,cholestasis,47,0.51477869339324,1.70727734997013,0.0116731517509728,0.0507616592453715,0.0340433929915015,DO,mono-sp-vs-hc
DOID:715,T-cell leukemia,53,0.479038711742448,1.64230726644488,0.0116731517509728,0.0507616592453715,0.0340433929915015,DO,mono-sp-vs-hc
DOID:0050624,gastrointestinal system benign neoplasm,41,0.476201184532139,1.59077758954872,0.01171875,0.0507616592453715,0.0340433929915015,DO,mono-sp-vs-hc
DOID:1070,primary open angle glaucoma,39,0.51800621633682,1.67102915143891,0.0119521912350598,0.0507616592453715,0.0340433929915015,DO,mono-sp-vs-hc
DOID:2151,malignant ovarian surface epithelial-stromal neoplasm,232,0.331485576470312,1.42903512133204,0.0119521912350598,0.0507616592453715,0.0340433929915015,DO,mono-sp-vs-hc
DOID:2152,ovary epithelial cancer,232,0.331485576470312,1.42903512133204,0.0119521912350598,0.0507616592453715,0.0340433929915015,DO,mono-sp-vs-hc
DOID:4001,ovarian carcinoma,232,0.331485576470312,1.42903512133204,0.0119521912350598,0.0507616592453715,0.0340433929915015,DO,mono-sp-vs-hc
DOID:9408,acute myocardial infarction,68,0.464709400681722,1.64341201015117,0.0119521912350598,0.0507616592453715,0.0340433929915015,DO,mono-sp-vs-hc
DOID:11934,head and neck cancer,196,0.315332054811497,1.31870002665522,0.0122448979591837,0.0516107510484178,0.0346128378513956,DO,mono-sp-vs-hc
DOID:341,peripheral vascular disease,49,0.488942992785827,1.65016197692623,0.0122950819672131,0.0516107510484178,0.0346128378513956,DO,mono-sp-vs-hc
DOID:3429,inclusion body myositis,13,0.662998334055219,1.70693834198123,0.0125523012552301,0.0523859046605558,0.035132695937973,DO,mono-sp-vs-hc
DOID:4254,osteosclerosis,15,0.658732785933245,1.68280074378617,0.0141843971631206,0.0588570962745578,0.0394726115852115,DO,mono-sp-vs-hc
DOID:1123,spondyloarthropathy,57,0.438212440316279,1.52089340092423,0.0148698884758364,0.0608820305253394,0.0408306371798456,DO,mono-sp-vs-hc
DOID:11612,polycystic ovary syndrome,125,0.37589161753865,1.47500862852322,0.0148698884758364,0.0608820305253394,0.0408306371798456,DO,mono-sp-vs-hc
DOID:767,muscular atrophy,41,0.465757530986983,1.56873372897234,0.0149253731343284,0.0608820305253394,0.0408306371798456,DO,mono-sp-vs-hc
DOID:655,inherited metabolic disorder,249,0.324511875968365,1.39551171531885,0.0152671755725191,0.0619264087829145,0.0415310512321631,DO,mono-sp-vs-hc
DOID:75,lymphatic system disease,82,0.404459042708669,1.49023124653037,0.0154440154440154,0.0620848292022271,0.0416372961554519,DO,mono-sp-vs-hc
DOID:6364,migraine,45,0.483597773673458,1.61133280376417,0.0155038759689922,0.0620848292022271,0.0416372961554519,DO,mono-sp-vs-hc
DOID:5157,benign pleural mesothelioma,38,0.478909674245154,1.5644378909393,0.0155642023346304,0.0620848292022271,0.0416372961554519,DO,mono-sp-vs-hc
DOID:1459,hypothyroidism,31,0.51617780097124,1.58919313968586,0.016597510373444,0.0658428708221239,0.0441576331508631,DO,mono-sp-vs-hc
DOID:8670,eating disorder,20,0.587252161905067,1.56614833968305,0.0168776371308017,0.0665882732701575,0.0446575385687016,DO,mono-sp-vs-hc
DOID:4645,retinal cancer,95,0.359310245110234,1.37703869887921,0.0181159420289855,0.0710853812224323,0.047673531655225,DO,mono-sp-vs-hc
DOID:10155,intestinal cancer,250,0.298686848333528,1.29200991978909,0.018450184501845,0.0720055849207141,0.0482906678284422,DO,mono-sp-vs-hc
DOID:0060116,sensory system cancer,111,0.356803726313901,1.39994341792399,0.0188679245283019,0.0728483503178287,0.0488558698734527,DO,mono-sp-vs-hc
DOID:2174,ocular cancer,111,0.356803726313901,1.39994341792399,0.0188679245283019,0.0728483503178287,0.0488558698734527,DO,mono-sp-vs-hc
DOID:10762,portal hypertension,15,0.596267146354578,1.53620512827088,0.0192307692307692,0.0732578432566257,0.04913049700838,DO,mono-sp-vs-hc
DOID:1398,parasitic infectious disease,120,0.391900997836893,1.53864334514013,0.0193050193050193,0.0732578432566257,0.04913049700838,DO,mono-sp-vs-hc
DOID:2789,parasitic protozoa infectious disease,102,0.40177994512972,1.52759960410199,0.0193050193050193,0.0732578432566257,0.04913049700838,DO,mono-sp-vs-hc
DOID:11476,osteoporosis,64,0.419479512979658,1.50558609127815,0.0193798449612403,0.0732578432566257,0.04913049700838,DO,mono-sp-vs-hc
DOID:574,peripheral nervous system disease,54,0.432251887381964,1.51508888441208,0.0199203187250996,0.0742676102699144,0.0498076989709296,DO,mono-sp-vs-hc
DOID:11054,urinary bladder cancer,83,0.370250708809461,1.41205609759215,0.02,0.0742676102699144,0.0498076989709296,DO,mono-sp-vs-hc
DOID:3149,keratoacanthoma,11,0.691171232794614,1.69475728349739,0.0200803212851406,0.0742676102699144,0.0498076989709296,DO,mono-sp-vs-hc
DOID:14221,metabolic syndrome X,17,0.590354280673221,1.59213313391605,0.0201612903225806,0.0742676102699144,0.0498076989709296,DO,mono-sp-vs-hc
DOID:2228,thrombocytosis,29,0.537264143920987,1.68692774975416,0.0201612903225806,0.0742676102699144,0.0498076989709296,DO,mono-sp-vs-hc
